Processing 00000000.tx.1: Gene and Protein Kinase Expression Profiling of Reactive Oxygen Species-Associated Lipotoxicity in the Pancreatic -Cell Line MIN6 Xiaolin Wang1,*, Hui Li1,2,*, Domenica De Leo1, Wanbei Guo2, Vasilij Koshkin1, I. 

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "Protein Kinase Expression Profiling of Reactive Oxygen Species-Associated Lipotoxicity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   777   C1327760:Protein Expression Profiling [Laboratory Procedure]
   766 E C3463810:protein expression profile [Laboratory or Test Result]
   760   C1513400:Expression Profiling [Molecular Biology Research Technique]
   757   C0444680:Protein profiling [Laboratory Procedure]
   706   C1979963:Profile [Laboratory Procedure]
   706   C2003903:Profile [Functional Concept]

Phrase: "in the Pancreatic -Cell Line MIN6 Xiaolin Wang1,"

Phrase: "*,"

Phrase: "Hui Li1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450477:LI1 [Body Location or Region]
   861   C1420713:LI1 [Gene or Genome]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "*,"

Phrase: "Domenica De Leo1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1825809:LEO1 [Gene or Genome]

Phrase: "Wanbei Guo2,"

Phrase: "Vasilij Koshkin1,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: George Fantus1,3, Adria Giacca1, Catherine B. 

Phrase: "George Fantus1,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Adria Giacca1,"

Phrase: "Catherine B."
Processing 00000000.tx.3: Chan4, Sandy Der2, and Michael B. 

Phrase: "Chan4,"

Phrase: "Sandy Der2,"

Phrase: "and"

Phrase: "Michael B."
Processing 00000000.tx.4: Wheeler1,3 1 Department of Physiology, University of Toronto, Toronto, Ontario, Canada 2 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada 3 Department of Medicine, University of Toronto, Toronto, Ontario, Canada 4 Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Oligonucleotide microarrays were used to define oleic acid (OA)-regulated gene expression and proteomic technology to screen protein kinases in MIN6 insulinoma cells. 

Phrase: "Wheeler1,"

Phrase: "3 1 Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada 2 Department of Laboratory Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pathobiology,"

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada 3 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada 4 Department of Biomedical Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "University of Prince Edward Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041740:University [Manufactured Object,Organization]

Phrase: "Charlottetown,"

Phrase: "Prince Edward Island,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033157:Prince Edward Island [Geographic Area]
   827   C0022130:Island [Geographic Area]

Phrase: "Canada  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oligonucleotide microarrays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600597:Oligonucleotide Microarrays [Medical Device,Research Device]
   827   C1709016:Microarray [Manufactured Object]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "oleic acid (OA)-regulated gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "proteomic technology to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:Technology [Occupation or Discipline]

Phrase: "screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "protein kinases in MIN6 insulinoma cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   783   C1419704:insulinoma protein [Gene or Genome]
   753   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.5: The effects of oxidative stress caused by OA and potential protective effects of N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS), on global gene expression and -cell function were investigated. 

Phrase: "The effects of oxidative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "caused by OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "potential protective effects of N-acetyl-L-cysteine (NAC),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "a scavenger of reactive oxygen species (ROS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017108:scavenger [Medical Device]
   753   C1003377:scavenger [Fish]

Phrase: "on global gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "were"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.6: Long-term exposure of MIN6 cells to OA led to a threefold increase in basal insulin secretion, a 50% decrease in insulin content, an inhibition of glucose-stimulated insulin secretion (GSIS), and a twofold increase in the level of ROS. 

Phrase: "Long-term exposure of MIN6 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]

Phrase: "to OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "led to a threefold increase"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in basal insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a 50% decrease in insulin content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "an inhibition of glucose-stimulated insulin secretion (GSIS),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C2250323:inhibition of insulin secretion [Cell Function]
   804   C2259158:inhibition of secretion [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "a twofold increase in the level of ROS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]
Processing 00000000.tx.7: The addition of NAC normalized both the OA-induced insulin content and ROS elevation, but it failed to restore GSIS. 

Phrase: "The addition of NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "both the OA-induced insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "ROS elevation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "but"

Phrase: "it"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "restore"

Phrase: "GSIS."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.8: Microarray studies and subsequent quantitative PCR analysis showed that OA consistently regulated the expression of 45 genes involved in metabolism, cell growth, signal transduction, transcription, and protein processing. 

Phrase: "Microarray studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "subsequent quantitative PCR analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C2733022:Quantitative PCR analysis [Laboratory Procedure]
   861   C0200931:PCR analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that OA consistently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   901   C0028929:Oleic Acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "the expression of 45 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025519:Metabolism [Organism Function]
   790   C0025520:metabolism [Functional Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "cell growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "signal transduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "protein processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033666:protein processing [Molecular Function]
   861   C1709694:Processing [Activity]
Processing 00000000.tx.9: The addition of NAC largely normalized the expression of the OA-regulated genes involved in cell growth and differentiation but not other functions. 

Phrase: "The addition of NAC largely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1883712:Addition [Functional Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "the expression of the OA-regulated genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "other functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.10: A protein kinase screen showed that OA regulated the expression and/or phosphorylation levels of kinases involved in stress-response mitogen-activated protein kinase, phosphatidylinositol 3-kinase, and cell cycle control pathways. 

Phrase: "A protein kinase screen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220908:screen [Health Care Activity]
   827   C1305399:screen [Functional Concept]
   827   C1705053:Screen [Medical Device]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "phosphorylation levels of kinases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "involved in stress-response mitogen-activated protein kinase,"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   822   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0149784:stress response [Physiologic Function]
   767   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0038435:Stress [Finding]
   744   C0871261:Response [Organism Attribute]
   744   C1314939:Involved [Functional Concept]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C1879547:Activated [Activity]
   744   C2911692:Response [Mental Process]
   711 E C1515877:Activate [Functional Concept]

Phrase: "phosphatidylinositol 3-kinase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cell cycle control pathways."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C0007586:Cell Cycle Pathway [Cell Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   756   C1155872:Cell Cycle Control [Cell Function]
Processing 00000000.tx.11: Importantly, these findings indicate that chronic OA exposure can impair -cell function through ROS-dependent and -independent mechanisms. 

Phrase: "Importantly,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that chronic OA exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]

Phrase: "can"

Phrase: "impair -"

Phrase: "cell function through ROS-dependent"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007613:Cell Function [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]

Phrase: "and -"

Phrase: "independent mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.12: Acute exposure to elevated free fatty acids (FFAs) in the plasma leads to enhanced insulin secretion from the pancreatic -cells, which then promotes the uptake of nutrients into the peripheral tissues (1). 

Phrase: "Acute exposure to elevated free fatty acids (FFAs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0205178:acute [Temporal Concept]
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "in the plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "leads to enhanced insulin secretion"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0181586:leads [Medical Device]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2349975:Enhanced [Activity]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from the pancreatic -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the uptake of nutrients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "into the peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: However, chronic exposure to elevated levels of plasma FFAs, such as that observed in obesity, has been implicated in the development of type 2 diabetes by the effects on insulin resistance in peripheral tissues and -cell dysfunction (2,3). 

Phrase: "However,"

Phrase: "chronic exposure to elevated levels of plasma FFAs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332157:Exposure to [Clinical Attribute]
           Exposure
   739   C0205191:chronic [Temporal Concept]
   739   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "such as that"

Phrase: "observed in obesity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]
   790   C1963185:Obesity [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the development of type 2 diabetes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0243107:development [Physiologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "by the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and -"

Phrase: "cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Long-term exposure to FFAs results in elevated basal insulin secretion with a concomitant suppression of glucose-stimulated insulin secretion (GSIS), elevated production of reactive oxygen species (ROS) (4), inhibition of insulin biosynthesis, and induction of -cell death both in vivo and in vitro (59). 

Phrase: "Long-term exposure to FFAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "results in elevated basal insulin secretion"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205112:Basal [Spatial Concept]
   753   C0205250:Elevated [Qualitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1546471:Result [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2825142:Result [Finding]
   753   C3163633:Elevated [Qualitative Concept]

Phrase: "with a concomitant suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]

Phrase: "of glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "elevated production of reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "(ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ")"

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "inhibition of insulin biosynthesis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "induction of -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.15: Together with insulin resistance in peripheral tissues, it is these lipotoxic effects resulting in -cell failure that are thought to precipitate the development of type 2 diabetes. 

Phrase: "Together with insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in peripheral tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "these lipotoxic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "resulting"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0678226:resulting [Functional Concept]
   966 E C1274040:Result [Functional Concept]
   966 E C1546471:Result [Idea or Concept]
   966 E C2825142:Result [Finding]

Phrase: "in -cell failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "that"

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "the development of type 2 diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
Processing 00000000.tx.16: While the mechanism of lipotoxicity in -cells is not well understood, previous studies have revealed that long-term exposure to FFAs results in changes in -cell metabolism, abnormal signal transduction, and altered expression of proteins at the level of both transcription and translation (5,7,8). 

Phrase: "While"

Phrase: "the mechanism of lipotoxicity in -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not well understood, previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that long-term exposure to FFAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332157:Exposure to [Clinical Attribute]
           Exposure
   744   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "results in changes in -cell metabolism,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0007634:Cell [Cell]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2825142:Result [Finding]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "abnormal signal transduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "altered expression of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1171362:expression protein [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of both transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.17: Studies of the effects of chronic FFA exposure on gene expression in islets and clonal -cell lines have examined both specific candidate genes as well as global gene expression (6,9,10). 

Phrase: "Studies of the effects of chronic FFA exposure"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "on gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in islets"

Phrase: "and"

Phrase: "clonal -cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   865   C0009013:Clone Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "both specific candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "as well as"

Phrase: "global gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(6,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.18: These analyses have produced a complex picture of transcriptional regulation by FFAs. 

Phrase: "These analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "produced"

Phrase: "a complex picture of transcriptional regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441468:picture [Manufactured Object]
   753   C0441469:Picture [Manufactured Object]

Phrase: "by FFAs."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.19: Long-term exposure to FFAs decreases acetyl-CoA carboxylase gene expression (11) and increases carnitine palmitoyltransferase 1 (CPT-1) gene expression leading to elevated FFA oxidation in INS-1 insulinoma cells (12). 

Phrase: "Long-term exposure to FFAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "acetyl-CoA carboxylase gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0001022:Acetyl-CoA Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "carnitine palmitoyltransferase 1 (CPT-1) gene expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0007262:Carnitine palmitoyltransferase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   717   C2258044:carnitine palmitoyltransferase I [Molecular Function]

Phrase: "leading to elevated FFA oxidation"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0015688:FFA [Lipid]
   760   C0030011:Oxidation [Molecular Function]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "INS-1 insulinoma cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.20: Microarray analysis of the effects of elevated concentrations of palmitate for up to 44 days has confirmed significant upregulation of genes related to fatty acid oxidation and downregulation of genes involved in glycolysis (10) consistent with the hypothesis of a glucose-fatty acid cycle (Randle cycle) (13,14). 

Phrase: "Microarray analysis of the effects of elevated concentrations of palmitate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1449575:Microarray Analysis [Laboratory Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "for"

Phrase: "up to 44 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "has"

Phrase: "confirmed significant upregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "related to fatty acid oxidation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C1158366:fatty acid oxidation [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0030011:Oxidation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "downregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0920533:Gene Down-Regulation [Genetic Function]
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "involved in glycolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017952:Glycolysis [Molecular Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "(10"

Phrase: ")"

Phrase: "consistent with the hypothesis of a glucose-fatty acid cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Randle cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.21: In islets cultured with palmitate for 48 h, pyruvate carboxylase (PC), peroxisome proliferator-activated receptor (PPAR)-, GLUT2, glucokinase, preproinsulin, and pancreatic/duodenal homeobox-1 mRNA levels were significantly decreased (9,15), implying a significant effect of FFAs on glucose metabolism and insulin biosynthesis. 

Phrase: "In islets"

Phrase: "cultured with palmitate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0030233:palmitate [Lipid]
   790   C3503116:palmitate [Biomedical or Dental Material,Lipid]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "for 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "pyruvate carboxylase (PC),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034340:PYRUVATE CARBOXYLASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418288:PYRUVATE CARBOXYLASE [Gene or Genome]
   861   C0007064:Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "peroxisome proliferator-activated receptor (PPAR)-,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "GLUT2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420172:GLUT2 [Gene or Genome]

Phrase: "glucokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "preproinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071928:Proinsulin, pre- [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "pancreatic/duodenal homeobox-1 mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(9,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "implying"

Phrase: "a significant effect of FFAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "insulin biosynthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]
Processing 00000000.tx.22: Furthermore, uncoupling protein (UCP)-2 mRNA and protein levels are significantly upregulated in INS-1 cells following 48 h incubation with oleic acid (OA), an effect that could be mediated through a PPAR- pathway (16,17). 

Phrase: "Furthermore,"

Phrase: "uncoupling protein (UCP)-2 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]

Phrase: "and"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "upregulated in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "48 h incubation with oleic acid"

Phrase: "(OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "mediated through a PPAR- pathway"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   770   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0752063:Peroxysome [Cell Component]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C1879547:Activated [Activity]
   744   C2984308:Peroxisome [Functional Concept]
   711 E C1515877:Activate [Functional Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.23: We have shown that the level of UCP2 mRNA correlates negatively with both ATP synthesis and GSIS in islets (1820) and correlate positively with the production of ROS (21). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the level of UCP2 mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "correlates"

Phrase: "negatively with both ATP synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1157223:ATP synthesis [Molecular Function]
   806   C1510700:ATP Synthesis [Functional Concept]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "GSIS in islets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1256369:insulin secretion [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(1820"

Phrase: ")"

Phrase: "and"

Phrase: "correlate"

Phrase: "positively with the production of ROS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0033268:production [Occupational Activity]
   744   C0205332:Reactive [Qualitative Concept]
   744   C1705920:Species [Conceptual Entity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.24: These observations implicate UCP2 upregulation as a potential mechanism linking chronic exposure to FFA with a diminished capacity for GSIS and a protective effect in the limitation of ROS production. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "implicate"

Phrase: "UCP2 upregulation as a potential mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "chronic exposure to FFA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0205191:chronic [Temporal Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "with a diminished capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "for GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a protective effect in the limitation of ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.25: Elevated FFAs leading to increased -oxidation and elevated ROS have been shown to contribute to the deterioration in islet function and -cell viability (22). 

Phrase: "Elevated FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "leading to increased -oxidation"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   802   C0861064:increased lead [Finding]
   770   C0030011:Oxidation [Molecular Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "elevated ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the deterioration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0868945:Deterioration [Phenomenon or Process]
   770   C1880177:Contribute [Activity]

Phrase: "in islet function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and -"

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.26: This might be due to the relatively low level of expression of antioxidant enzymes such as superoxide dismutase and glutathione peroxidase in islets (23). 

Phrase: "This"

Phrase: "might"

Phrase: "be due to the relatively low level of expression of antioxidant enzymes"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   753   C0678226:Due to [Functional Concept]
           due
   751   C0014440:enzymes level [Laboratory Procedure]
   751   C1287349:enzymes level [Laboratory or Test Result]
   751   C3244092:expression level [Idea or Concept]
   736   C0003402:Antioxidant [Pharmacologic Substance]
   736   C0014442:Enzymes [Enzyme,Organic Chemical]
   736   C0014445:enzymes [Functional Concept]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205251:low [Qualitative Concept]
   736   C0441889:Level [Qualitative Concept]
   736   C0456079:Level [Classification]
   736   C1299352:Low [Qualitative Concept]
   736   C1547707:Level [Geographic Area]
   736   C1550472:low [Idea or Concept]
   736   C2946261:Level [Pharmacologic Substance]
   736   C2987476:Be [Conceptual Entity]
   736   C3146286:Due [Idea or Concept]

Phrase: "such as superoxide dismutase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "glutathione peroxidase in islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   770   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.27: Several studies have demonstrated that antioxidants such as N-acetyl-L-cysteine (NAC), aminoguanidine, and a combination of vitamins E and C can, at least in part, block the ROS-induced effects of chronic hyperglycemia (glucotoxicity) in -cells (24,25), but the effectiveness of antioxidants in reversing FFA-mediated damage is less clear and hence the focus of the present study.  

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that antioxidants such as N-acetyl-L-cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "(NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ")"

Phrase: ","

Phrase: "aminoguanidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "a combination of vitamins E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "C"

Phrase: "can"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the ROS-induced effects of chronic hyperglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "(glucotoxicity"

Phrase: ")"

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the effectiveness of antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1280519:Effectiveness [Qualitative Concept]

Phrase: "in reversing FFA-mediated damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "hence"

Phrase: "the focus of the present study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205234:Focus [Spatial Concept]
   753   C1285542:focus [Functional Concept]
Processing 00000000.tx.28: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Reagents. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.29: NAC, OA, cycloheximide (CHX), -actin antibody, and BSA (fatty acid free) were purchased from Sigma-Aldrich (Oakville ON, Canada). 

Phrase: "NAC,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "OA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "cycloheximide (CHX), -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "actin antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "BSA (fatty acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Sigma-Aldrich"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0869011:purchased [Activity]
   770   C1719918:Sigma [Intellectual Product]

Phrase: "(Oakville ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.30: OA bound to BSA was prepared by stirring 4 mmol/l OA with 5% (wt/vol) BSA in Krebs-Ringer HEPES buffer (KRB) (125 mmol/l NaCl, 5.9 mmol/l KCl, 1.28 mmol/l CaCl2, 5.0 mmol/l NaCO3, and 25 mmol/l HEPES) for 30 min at 50C. 

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "bound to BSA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "prepared by stirring 4 mmol/l OA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0028929:Oleic Acid [Lipid]
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439190:MMOLE [Quantitative Concept]
   711   C1521827:Prepare [Functional Concept]

Phrase: "with 5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(wt/vol) BSA in Krebs-Ringer HEPES buffer (KRB)"

Phrase: "(125 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "5.9 mmol/l KCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "1.28 mmol/l CaCl2,"

Phrase: "5.0 mmol/l NaCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "and"

Phrase: "25 mmol/l HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 50C."
Processing 00000000.tx.31: All solutions were adjusted to pH 7.0, filtered through a 0.22-m filter, and stored at -20C until required. 

Phrase: "All solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "adjusted to pH 7.0,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1882074:pH 7 [Qualitative Concept]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C0456081:Adjusted [Functional Concept]

Phrase: "filtered through a 0.22-m filter,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   714   C0180860:Filter [Manufactured Object]
   714   C0581406:Filter [Medical Device]
   714   C1522664:Filter [Intellectual Product]
   714   C1704449:Filter [Conceptual Entity]
   714   C1704684:Filter [Medical Device]
   714   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -20C"

Phrase: "until"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.32: TRIzol and SuperScript II RNase H-Reverse Transcriptase kits were from Invitrogen (Burlington ON, Canada). 

Phrase: "TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "and"

Phrase: "SuperScript II RNase H-Reverse Transcriptase kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   795   C1690540:Kits [Qualitative Concept]
   762 E C0812225:KIT [Medical Device]
   762 E C1150635:KIT [Molecular Function]
   762 E C1705212:Kit [Medical Device]
   762 E C1705213:KIT [Medical Device]
   762 E C3273202:Kit [Manufactured Object]

Phrase: "were from Invitrogen"

Phrase: "(Burlington ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.33: HotStarTaq PCR kits and RNeasy kits were purchased from Qiagen (Mississauga ON, Canada). 

Phrase: "HotStarTaq PCR kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C1690540:Kits [Qualitative Concept]
   793 E C0812225:KIT [Medical Device]
   793 E C1150635:KIT [Molecular Function]
   793 E C1705212:Kit [Medical Device]
   793 E C1705213:KIT [Medical Device]
   793 E C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "RNeasy kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C1690540:Kits [Qualitative Concept]
   827 E C0812225:KIT [Medical Device]
   827 E C1150635:KIT [Molecular Function]
   827 E C1705212:Kit [Medical Device]
   827 E C1705213:KIT [Medical Device]
   827 E C3273202:Kit [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Qiagen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Mississauga ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.34: SYBR Green was a product of Molecular Probes (Eugene, OR). 

Phrase: "SYBR Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "was"

Phrase: "a product of Molecular Probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "(Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.35: Enzo BioArray High Yield RNA Transcript Labeling kits and U74AV2 murine genome microarrays were purchased from Affymetrix (Santa Clara, CA). 

Phrase: "Enzo BioArray High Yield RNA Transcript Labeling kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   793   C1690540:Kits [Qualitative Concept]
   760 E C0812225:KIT [Medical Device]
   760 E C1150635:KIT [Molecular Function]
   760 E C1705212:Kit [Medical Device]
   760 E C1705213:KIT [Medical Device]
   760 E C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "U74AV2 murine genome microarrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1709016:Microarray [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Affymetrix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Santa Clara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551532:Santa Clara [Population Group]

Phrase: "CA)."
Processing 00000000.tx.36: Antibodies against phospho-p70 S6 kinase (Thr389), phospho-Akt (Thr308), and phospho-retinoblastoma (Rb) (Ser780) were purchased from Cell Signaling Technology (Beverly, MA). 

Phrase: "Antibodies against phospho-p70 S6 kinase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Thr389"

Phrase: ")"

Phrase: ","

Phrase: "phospho-Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(Thr308"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "phospho-retinoblastoma (Rb)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035335:Retinoblastoma [Neoplastic Process]
   861   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "(Ser780"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Cell Signaling Technology"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C0869011:purchased [Activity]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.37: p38 mitogen-activated protein kinase (MAPK) and PKG were from Stressgen Biotechnologies (Victoria BC, Canada); 

Phrase: "p38 mitogen-activated protein kinase (MAPK)"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKG"

Phrase: "were from Stressgen Biotechnologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005574:Biotechnologies [Biomedical Occupation or Discipline]

Phrase: "(Victoria BC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984916:BC [Quantitative Concept]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.38: p70 S6 kinase, raf-1, G protein-coupled receptor kinase 2, protein kinase C (PKC)-, cyclin-dependent kinase 7, and focal adhesion kinase antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). 

Phrase: "p70 S6 kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1136240:p70 S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "raf-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "G protein-coupled receptor kinase 2,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
  1000   C0753114:G-Protein-Coupled Receptor Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   947   C0872043:G Protein-Coupled Receptor Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   941   C0667720:G Protein-Coupled Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   941   C1333692:G PROTEIN-COUPLED RECEPTOR 2 [Gene or Genome]
   941   C1425983:G PROTEIN-COUPLED RECEPTOR 2 [Gene or Genome]
   941   C1872959:G-Protein Coupled Receptor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   876   C0010536:G-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439267:g% [Quantitative Concept]
   799   C1948027:Coupled [Functional Concept]
   766 E C0010222:couple [Family Group]

Phrase: "protein kinase C (PKC)-,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cyclin-dependent kinase 7,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0255652:Cyclin-Dependent Kinase 7 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413288:CYCLIN-DEPENDENT KINASE 7 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "focal adhesion kinase antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0059239:Focal Adhesion Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1366894:FOCAL ADHESION KINASE [Gene or Genome]
   756   C1565434:Focal Adhesion Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were from Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.39: Jun NH2-terminal kinase (JNK)-3/MAPK 10 antibody was from Upstate Biotechnology (Charlottesville, VA). 

Phrase: "Jun NH2-terminal kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1334482:Jun kinase [Gene or Genome]
   902   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(JNK)-3/MAPK 10 antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   836   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   723   C0380362:Mitogen-Activated Protein Kinase 10 [Amino Acid, Peptide, or Protein,Enzyme]
   723   C1334478:MITOGEN-ACTIVATED PROTEIN KINASE 10 [Gene or Genome]
   723   C1455843:Mitogen-Activated Protein Kinase 10 [Amino Acid, Peptide, or Protein,Enzyme]
   703   C0248813:JNK Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was from Upstate Biotechnology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(Charlottesville,"

Phrase: "VA)."
Processing 00000000.tx.40: MAPK kinase (MEK)-2 antibody was purchased from BD Biosciences (Mississauga ON, Canada); 

Phrase: "MAPK kinase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   958   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(MEK)-2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from BD Biosciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "(Mississauga ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.41: stromal cell-derived factor (Sdf)-1 antibody was from R&D Systems (Minneapolis, MN). 

Phrase: "stromal cell-derived factor (Sdf)-1 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   780   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   780   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]

Phrase: "was from R&D Systems"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0205090:R- [Spatial Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0684010:R. [Professional or Occupational Group]
   760   C1421478:WAS [Gene or Genome]
   760   C2603358:R' [Clinical Attribute]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "(Minneapolis,"

Phrase: "MN"

Phrase: ")."
Processing 00000000.tx.42: VILIP-1 antibody was kindly provided by Dr. 

Phrase: "VILIP-1 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   722   C1421472:VISININ-LIKE 1 [Gene or Genome]
   717   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.43: K.-H. 

Phrase: "K.-H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.44: Braunewell (Humboldt University, Berlin, Germany). 

Phrase: "Braunewell"

Phrase: "(Humboldt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.45: Cell culture and treatment. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.46: MIN6 cells, a gift from Dr. 

Phrase: "MIN6 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "a gift from Dr."
Processing 00000000.tx.47: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.48: Seino, Chiba University (passage number 3545), were cultured in Dulbeccos modified Eagles medium (DMEM) containing 25 mmol/l glucose supplemented with 10% fetal bovine serum, 48.6 mol/l -mercaptoethanol, 100 units/ml penicillin, and 100 g/ml streptomycin, at 37C in a humidified atmosphere (5% CO2, 95% air). 

Phrase: "Seino,"

Phrase: "Chiba University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "(passage number 3545"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0237753:*Number [Quantitative Concept]
   827   C0439799:Passage [Spatial Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "cultured in Dulbeccos modified Eagles medium (DMEM)"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagles [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1551720:Eagle [Population Group]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "25 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "48.6 mol/l -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "100 units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "at 37C"

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "(5% CO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "95% air"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001861:Air [Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.49: Cells were grown in monolayer to 80% confluency in 100-mm2 dishes or 24-well plates. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in monolayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0872351:monolayer [Clinical Drug]

Phrase: "to 80% confluency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205200:Confluent [Qualitative Concept]

Phrase: "in 100-mm2 dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "or"

Phrase: "24-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.50: Cells were then incubated overnight in DMEM containing 10 mmol/l glucose, followed by treatment for 72 h with either 1) 0.5% (wt/vol) BSA, 2) 0.4 mmol/l OA in BSA, 3) 0.4 mmol/l OA in BSA plus 1 mmol/l NAC, or 4) 1 mmol/l NAC in BSA. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight in DMEM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagles [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C1551720:Eagle [Population Group]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with either 1"

Phrase: ")"

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(wt/vol) BSA,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "0.4 mmol/l OA in BSA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0028929:Oleic Acid [Lipid]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "0.4 mmol/l OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   827   C0028929:Oleic Acid [Lipid]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: "in BSA plus 1 mmol/l NAC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   842   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   817   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "4"

Phrase: ")"

Phrase: "1 mmol/l NAC in BSA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0001047:acetyl cysteine l n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   762   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.51: Insulin secretion and insulin content measurement. 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin content measurement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0202098:Insulin measurement [Laboratory Procedure]
   827   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.52: MIN6 cells cultured in 24-well plates were preincubated for two sequential periods of 30 min in glucose-free KRB containing 0.1% (wt/vol) BSA in a 37C humidified air incubator. 

Phrase: "MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in 24-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "preincubated for two sequential periods of 30 min"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0456693:/30 min [Temporal Concept]
   770   C1442458:30 min [Temporal Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1548958:Sequential [Idea or Concept]
   744   C1705294:Sequential [Qualitative Concept]
   711   C0439531:/period [Temporal Concept]
   711   C1948053:Period [Temporal Concept]

Phrase: "in glucose-free KRB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1%"

Phrase: "(wt/vol) BSA in a 37C humidified air incubator."
Processing 00000000.tx.53: The cells were then incubated in the same buffer with glucose concentrations ranging from 0 to 30 mmol/l for 30 min. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in the same buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "ranging from 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 30 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.54: At the end of the experiment, the supernatant was collected and centrifuged (300g/10 min) to remove cellular debris. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(300g/10 min) to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456692:/10 min [Temporal Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "cellular debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]
Processing 00000000.tx.55: The concentration of insulin in the supernatant was determined by radioimmunoassay as previously described (26). 

Phrase: "The concentration of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "determined by radioimmunoassay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.56: Insulin secretion measurements were normalized to total DNA content in the sample. 

Phrase: "Insulin secretion measurements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0202098:Insulin measurement [Laboratory Procedure]
   827   C0242485:measurements [Functional Concept]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "were"

Phrase: "normalized to total DNA content"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0423896:Content [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1882115:Normalized [Research Activity]

Phrase: "in the sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.57: The total cellular insulin content was extracted using 75% ethanol containing 1.5% (vol/vol) HCl. 

Phrase: "The total cellular insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "75% ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.5%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(vol/vol) HCl."
Processing 00000000.tx.58: Insulin content was reported as the amount of insulin per microgram DNA. 

Phrase: "Insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "reported as the amount of insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1265611:Amount [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "per microgram DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.59: ROS measurement. 

Phrase: "ROS measurement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0523806:Oxygen measurement [Laboratory Procedure]
   812   C0242485:Measurement [Functional Concept]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.60: MIN6 cells were harvested following treatment by 0.05% (wt/vol) trypsin containing 0.5 mmol/l EDTA. 

Phrase: "MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment by 0.05%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(wt/vol) trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5 mmol/l EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.61: The harvested cells were washed in Ca2+-free KRB buffer and permeabilized using 80 g/ml saponin as described elsewhere (27). 

Phrase: "The harvested cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed in Ca2+-free KRB buffer"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0332296:free [Functional Concept]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1548982:Washed [Idea or Concept]
   742   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]
   708 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "permeabilized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "80 g/ml saponin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520481:Saponin [Steroid]
   812   C0885750:saponin [Organic Chemical]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.62: Hydrogen peroxide (H2O2) production in -cell mitochondria was measured in permeabilized cells fluorometrically by monitoring the catalase-sensitive conversion of dichlorofluorescin to dichlorofluorescein (excitation 490 nm, emission 530 nm) in the presence of horseradish peroxidase (28,29). 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "production in -cell mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0026237:Mitochondria [Cell Component]

Phrase: "was"

Phrase: "measured in permeabilized cells fluorometrically"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0444706:Measured [Qualitative Concept]
   760   C3282337:Cells [Cell]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]

Phrase: "the catalase-sensitive conversion of dichlorofluorescin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]

Phrase: "to dichlorofluorescein"

Phrase: "(excitation 490 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "emission 530 nm) in the presence of horseradish peroxidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0312860:NM [Cell Function]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.63: The reaction was started by addition of 5 mmol/l glutamate and 5 mmol/l malate as a mitochondrial respiratory substrate and 1 mol/l antimycin A, an inhibitor of electron transfer. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started by addition of 5 mmol/l glutamate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   744   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439190:MMOLE [Quantitative Concept]
   744   C1272689:Started [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   711 E C0439659:Start [Temporal Concept]

Phrase: "and"

Phrase: "5 mmol/l malate as a mitochondrial respiratory substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0220873:malate [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "1 mol/l antimycin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0003387:Antimycin A [Antibiotic,Organic Chemical]
   804   C0052078:antimycin [Antibiotic,Organic Chemical]

Phrase: "an inhibitor of electron transfer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.64: Dichlorofluorescin was obtained from the stable compound dichlorofluorescin diacetate by alkaline hydrolysis (28). 

Phrase: "Dichlorofluorescin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965324:dichlorofluorescin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "obtained from the stable compound dichlorofluorescin diacetate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205198:Compound [Qualitative Concept]
   748   C0205360:Stable [Qualitative Concept]
   748   C0369114:Diacetate [Organic Chemical]
   748   C0965324:dichlorofluorescin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1301820:Obtained [Functional Concept]
   748   C1547311:Stable [Intellectual Product]
   748   C1706082:Compound [Chemical]
   714 E C1706701:Obtain [Activity]

Phrase: "by alkaline hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.65: RNA extraction and gene expression profiling. 

Phrase: "RNA extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "gene expression profiling."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C1449575:Gene Expression Profiling [Laboratory Procedure]
   983 E C1956267:Profile, Gene Expression [Quantitative Concept]
   901   C1513400:Expression Profiling [Molecular Biology Research Technique]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]
   734   C0017262:Gene Expression [Genetic Function]
Processing 00000000.tx.66: Total RNA was isolated from MIN6 cells using TRIzol reagent and further purified with RNeasy kits according to the manufacturers instructions. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from MIN6 cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified with RNeasy kits"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1690540:Kits [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]
   737 E C0812225:KIT [Medical Device]
   737 E C1150635:KIT [Molecular Function]
   737 E C1705212:Kit [Medical Device]
   737 E C1705213:KIT [Medical Device]
   737 E C3273202:Kit [Manufactured Object]

Phrase: "according to the manufacturers instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.67: Double-stranded cDNA was prepared using SuperScript II RT and T7-(dT)24 primers to initiate reverse transcription of mRNA in the sample. 

Phrase: "Double-stranded cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SuperScript II RT"

Phrase: "and"

Phrase: "T7-(dT)24 primers to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "reverse transcription of mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0035380:Reverse Transcription [Genetic Function]
   819   C1158816:mRNA transcription [Genetic Function]
   770   C0040649:Transcription [Genetic Function]
   770   C1555029:Reverse [Idea or Concept]

Phrase: "in the sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.68: The biotin-labeled cRNA was then synthesized using the BioArray HighYield RNA transcript labeling kit, purified by RNeasy columns, fragmented to a mean size of 50100 nucleotides, and then hybridized to murine genome U74A microarrays version 2 according to the Affymetrix instructions. 

Phrase: "The biotin-labeled cRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1321571:CRNA [Professional or Occupational Group]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BioArray HighYield RNA transcript labeling kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]

Phrase: "purified by RNeasy columns,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1998793:Purified [Functional Concept]
   737   C1185738:Column [Body Part, Organ, or Organ Component]
   737   C1706132:Column [Idea or Concept]

Phrase: "fragmented to a mean size of 50100 nucleotides,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0392767:Fragmented [Functional Concept]
   744   C0444504:Mean [Quantitative Concept]
   744   C0456389:size [Spatial Concept]
   744   C1708096:Fragmented [Qualitative Concept]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]
   711 E C0332255:fragment [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "hybridized to murine genome U74A microarrays version 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0017428:Genome [Gene or Genome]
   744   C0026809:Murine [Mammal]
   744   C0333052:Version [Functional Concept]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C2338314:Genome [Conceptual Entity]
   744   C2607870:Version [Spatial Concept]
   711   C1709016:Microarray [Manufactured Object]

Phrase: "according to the Affymetrix instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.69: Microarrays were washed, stained with streptavidin-phycoerythrin, and scanned using Affymetrix GeneChip Fluidics Station 400 and Scanner. 

Phrase: "Microarrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709016:Microarray [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "stained with streptavidin-phycoerythrin,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0031789:Phycoerythrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Affymetrix GeneChip Fluidics Station 400"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0872345:Gene Chip [Medical Device,Research Device]
   804   C1883167:Station [Manufactured Object]
   804   C1955272:Genechip [Manufactured Object]
   733 E C0439835:Stationary [Qualitative Concept]

Phrase: "and"

Phrase: "Scanner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183115:scanner [Medical Device]
  1000   C1710020:Scanner [Medical Device]
Processing 00000000.tx.70: Expression of genes that were deemed significantly altered by OA treatment according to Microarray Suite version 5.0 statistical analysis software (Affymetrix, Santa Clara, CA) in at least three of four independent experiments were chosen and further classified according to biological function. 

Phrase: "Expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "were"

Phrase: "deemed"

Phrase: "significantly"

Phrase: "altered by OA treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   806   C0028929:Oleic Acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0392747:Altered [Functional Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "according to Microarray Suite version 5.0 statistical analysis software"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   878   C1449575:Microarray Analysis [Laboratory Procedure]
   812   C0871424:statistical analysis [Research Activity]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0037585:Software [Intellectual Product,Manufactured Object]
   793   C0038215:Statistical [Occupation or Discipline]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "(Affymetrix,"

Phrase: "Santa Clara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551532:Santa Clara [Population Group]

Phrase: "CA) in"

Phrase: "at least three"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205449:Three [Quantitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "classified according to biological function."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0031845:Biological function, NOS [Physiologic Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0008902:Classified [Classification]
   760   C0031843:function [Physiologic Function]
   760   C0205460:biological [Qualitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.71: Real-time PCR. 

Phrase: "Real-time PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]
Processing 00000000.tx.72: Total RNA was converted to cDNA using SuperScript II RT. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "converted to cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SuperScript II RT."
Processing 00000000.tx.73: Amplification of each target cDNA was performed with HotStarTaq PCR reagent kits in the ABI PRISM 7900HT sequence detection system according to the protocols provided by the manufacturer (PE Applied Biosystems, Foster City, CA). 

Phrase: "Amplification of each target cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed with HotStarTaq PCR reagent kits"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   753   C0677874:pCR [Finding]
   753   C0884358:Performed [Functional Concept]
   753   C1690540:Kits [Qualitative Concept]
   719 E C0812225:KIT [Medical Device]
   719 E C1150635:KIT [Molecular Function]
   719 E C1705212:Kit [Medical Device]
   719 E C1705213:KIT [Medical Device]
   719 E C2947996:Perform [Pharmacologic Substance]
   719 E C3273202:Kit [Manufactured Object]

Phrase: "in the ABI PRISM 7900HT sequence detection system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "according to the protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "provided by the manufacturer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Provided [Activity]

Phrase: "(PE Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.74: PCR products were quantified fluorometrically using SYBR Green. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "quantified"

Phrase: "fluorometrically"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR Green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.75: -Actin expression in each sample was used as a control. 

Phrase: "-Actin expression in each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "used as a control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.76: Two different primer sets were designed and synthesized for each investigated gene or expressed sequence tag (EST) using Primer Express version 2.0 (Applied Biosystems). 

Phrase: "Two different primer sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "and"

Phrase: "synthesized for each investigated gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017337:Gene [Gene or Genome]
   760   C1292732:investigated [Functional Concept]
   760   C1883254:Synthesized [Activity]

Phrase: "or"

Phrase: "expressed sequence tag (EST)"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0600510:Expressed Sequence Tag [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0037293:Tag [Neoplastic Process]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0181496:Tag [Manufactured Object]
   827   C1519249:Sequence [Functional Concept]
   827   C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Express"

Phrase: "version 2.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.77: A standard curve of each primer set was generated using mouse genomic DNA. 

Phrase: "A standard curve of each primer set"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mouse genomic DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
Processing 00000000.tx.78: One primer set was chosen for each gene to perform all the subsequent PCR to ensure better PCR efficiency and standard curve lineage. 

Phrase: "One primer set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "was"

Phrase: "chosen for each gene to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017337:Gene [Gene or Genome]
   760   C1707391:Chosen [Activity]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "all the subsequent PCR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "better PCR efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "and"

Phrase: "standard curve lineage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881379:Lineage [Conceptual Entity]
Processing 00000000.tx.79: Primer sequences will be provided on request. 

Phrase: "Primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "will"

Phrase: "be"

Phrase: "provided on request."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.80: Protein kinase and phosphorylation profiling. 

Phrase: "Protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "phosphorylation profiling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]
Processing 00000000.tx.81: Whole cell proteins were extracted from MIN6 cells using lysis buffer (20 mmol/l MOPS, pH 7.0, 2 mmol/l EGTA, 5 mmol/l EDTA, 30 mmol/l sodium fluoride, 40 mmol/l -glycerophosphate, 10 mmol/l sodium pyrophosphate, 2 mmol/l sodium orthovanadate, 1 mmol/l phenylmethylsulfonylfluoride, 3 mmol/l benzamidine, 5 mol/l pepstatin A, 10 mol/l leupeptin, 0.5% nonidet P-40, and 0.5% Triton X-100). 

Phrase: "Whole cell proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "extracted from MIN6 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   770   C3541890:EXTRACTED [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20 mmol/l MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0066823:MOPS [Organic Chemical]
   812   C1271466:Mops [Mammal]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 mmol/l EDTA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "30 mmol/l sodium fluoride,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0037508:Sodium Fluoride [Biomedical or Dental Material,Inorganic Chemical]
   840   C1171560:sodium fluoride [Pharmacologic Substance]
   840   C1556062:Sodium Fluoride [Intellectual Product]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   784 E C0721463:Luride [Organic Chemical,Pharmacologic Substance]

Phrase: "40 mmol/l -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "10 mmol/l sodium pyrophosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 mmol/l sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0029366:Orthovanadate [Inorganic Chemical]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1 mmol/l phenylmethylsulfonylfluoride,"

Phrase: "3 mmol/l benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "5 mol/l pepstatin A,"

Phrase: "10 mol/l leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "0.5% nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "0.5% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")."
Processing 00000000.tx.82: The expression of 75 protein kinases was assessed by Kinetworks KPKS 1.0 Western blot analysis (Kinexus Bioinformatics, Vancouver, Canada). 

Phrase: "The expression of 75 protein kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed by Kinetworks KPKS 1.0 Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1516048:Assessed [Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]

Phrase: "(Kinexus Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "Vancouver,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.83: Phosphoprotein profiling was performed by Kinetworks KPPS 1.1 (36 different phosphorylation sites). 

Phrase: "Phosphoprotein profiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "performed by Kinetworks KPPS 1.1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(36 different phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C1519063:Phosphorylation Site [Amino Acid Sequence]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205145:Sites [Spatial Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.84: Expression levels of kinase and phosphokinases in control cells were categorized according to the trace quantity (TQ) value with a TQ of 2,000 considered the threshold for detection (according to the service provider). 

Phrase: "Expression levels of kinase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C3244092:expression level [Idea or Concept]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphokinases in control cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:phosphokinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "categorized according to the trace quantity (TQ) value"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0442822:Trace [Quantitative Concept]
   748   C0680240:according [Social Behavior]
   748   C0871968:categorized [Activity]
   748   C1265611:Quantity [Quantitative Concept]
   748   C1522609:Value [Quantitative Concept]
   748   C1524031:Trace [Qualitative Concept]
   748   C1554108:Quantity [Intellectual Product]
   748   C1561573:Quantity [Intellectual Product]
   748   C1883002:Trace [Functional Concept]

Phrase: "with a TQ"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1265611:Quantity [Quantitative Concept]
   861   C1554108:Quantity [Intellectual Product]
   861   C1561573:Quantity [Intellectual Product]

Phrase: "of 2,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the threshold for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449864:Threshold [Qualitative Concept]

Phrase: "("

Phrase: "according to the service provider"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1138603:Provider [Professional or Occupational Group]
   861   C1441436:{Provider} [Health Care Activity]
   861   C1555587:provider [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.85: Kinases with a TQ of 2,0005,000 were considered to be expressed at low levels, whereas a TQ >5,000 was considered an indicator of high expression. 

Phrase: "Kinases with a TQ of 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "0005,"

Phrase: "000"

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed at low levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "a TQ"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1265611:Quantity [Quantitative Concept]
   861   C1554108:Quantity [Intellectual Product]
   861   C1561573:Quantity [Intellectual Product]

Phrase: ">5,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "an indicator of high expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   760   C1235732:Indicator [Bird]
   760   C1522602:Indicator [Functional Concept]
Processing 00000000.tx.86: Kinases with a TQ <2,000 were not included in the analyses. 

Phrase: "Kinases with a TQ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "<2,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included in the analyses."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332257:included [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.87: The criterion for a significant change in kinase or phosphorylation levels for treated samples was a consistent change in the relative quantity value of >1.25-fold over the control (BSA only) level for at least two of three independent experiments. 

Phrase: "The criterion for a significant change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:Criterion [Intellectual Product]

Phrase: "in kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "phosphorylation levels for treated samples"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "a consistent change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "in the relative quantity value of >1.25-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0332462:Fold [Spatial Concept]
   795   C1880834:FOLD [Phenomenon or Process]

Phrase: "over the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(BSA only"

Phrase: ")"

Phrase: "level for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0441889:Level [Qualitative Concept]
   833   C0456079:Level [Classification]
   833   C1547707:Level [Geographic Area]
   833   C2946261:Level [Pharmacologic Substance]

Phrase: "at least two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.88: The kinases consistently regulated by OA were then further validated with conventional Western blotting (30). 

Phrase: "The kinases consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulated by OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "then further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883708:Then [Temporal Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "validated with conventional Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C0439858:Conventional [Qualitative Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.89: The effects of NAC on OA-induced regulation of kinases were also examined by Western blotting. 

Phrase: "The effects of NAC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on OA-induced regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0851285:Regulation [Governmental or Regulatory Activity]
   812   C1327622:Regulation [Biologic Function]

Phrase: "of kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "also"

Phrase: "examined by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.90: Band density was measured by densitometry, analyzed using image analysis software (Scion Image version 4.02; Scion, Frederick, MD), and normalized to -actin content in parallel samples. 

Phrase: "Band density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "measured by densitometry,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "image analysis software"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
   734   C0200765:Image analysis [Laboratory Procedure]

Phrase: "(Scion Image version 4.02"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0333052:Version [Functional Concept]
   804   C1704254:Image [Intellectual Product]
   804   C1704922:Image [Entity]
   804   C2607870:Version [Spatial Concept]
   804   C3542466:Image [Intellectual Product]

Phrase: "; Scion,"

Phrase: "Frederick,"

Phrase: "MD),"

Phrase: "and"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to -actin content in parallel samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0370003:Sample [Substance]
   766   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.91: Examination of posttranscriptional regulation of insulin levels. 

Phrase: "Examination of posttranscriptional regulation of insulin levels."
Processing 00000000.tx.92: CHX, an inhibitor of protein translation, was used to investigate protein translation and stability (31). 

Phrase: "CHX,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "an inhibitor of protein translation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "protein translation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Translation [Molecular Function]
           translation
   861   C0040712:Translation [Intellectual Product]
   861   C1519614:Translation [Genetic Function]

Phrase: "and"

Phrase: "stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: Briefly, MIN6 cells were treated with OA and/or NAC as indicated above with or without 5 mol/l CHX for 36 h. 

Phrase: "Briefly,"

Phrase: "MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with OA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and/or"

Phrase: "NAC as indicated above"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   778   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "with"

Phrase: "or without 5 mol/l CHX"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "for 36 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.94: Insulin content was measured as described above. 

Phrase: "Insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured as described above."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0444706:Measured [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.95: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.96: Data are expressed as means  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.97: Statistical analysis was performed using ANOVA and Students t test. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"

Phrase: "and"

Phrase: "Students t test."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:Students [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   793 E C1551041:student [Idea or Concept]
   793 E C1552573:student [Intellectual Product]
Processing 00000000.tx.98: Differences were deemed to be significant when P < 0.05.  

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "deemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "when"

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.99: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The effects of OA and/or NAC on insulin secretion and content in MIN6 cells. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "NAC on insulin secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   778   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "and"

Phrase: "content in MIN6 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.100: OA increased basal insulin secretion from 115.7  16.8 to 369.4  26.7 pg insulin/g DNA, but decreased insulin secretion induced by glucose (Fig. 1A). 

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "basal insulin secretion from 115.7  16.8"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1256369:insulin secretion [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "to 369.4  26.7 pg insulin/g DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "decreased insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induced by glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.101: Coincubation with NAC did not improve the insulin secretion in response to glucose or normalize increased basal insulin secretion in OA-exposed MIN6 cells. 

Phrase: "Coincubation with NAC"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "improve"

Phrase: "the insulin secretion in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "increased basal insulin secretion in OA-exposed MIN6 cells."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   777   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   760   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1256369:insulin secretion [Cell Function]
   757   C0020459:increased insulin [Disease or Syndrome]
   757   C1160577:acid secretion [Cell Function]
   741   C0030281:Insulin Cell [Cell]
   741   C1327616:Cell secretion [Cell Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.102: NAC in the absence of OA had no effect on insulin secretion. 

Phrase: "NAC in the absence of OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   760   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "had"

Phrase: "no effect on insulin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.103: OA decreased insulin content in MIN6 cells by 50% compared with BSA control (from 12.7  1.2 to 6.2  0.8 ng insulin/g DNA, P < 0.001 for BSA vs. OA) (Fig. 1B). 

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "insulin content in MIN6 cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   781   C0030281:Insulin Cell [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by 50%"

Phrase: "compared with BSA control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "from 12.7  1.2"

Phrase: "to 6.2  0.8 ng insulin/g DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "P < 0.001 for BSA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: "vs. OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: However, coincubation with NAC restored insulin content from 6.22  0.81 ng/g DNA in OA-treated MIN6 cells to 10.43  0.72 ng/g DNA in OA plus NAC-treated cells (P = 0.14 for BSA vs. NAC + OA and P < 0.05 for OA vs. NAC + OA; n = 5). 

Phrase: "However,"

Phrase: "coincubation with NAC"

Phrase: "restored"

Phrase: "insulin content from 6.22  0.81 ng/g DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in OA-treated MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "to 10.43  0.72 ng/g DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in OA plus NAC-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]

Phrase: "(P = 0.14 for BSA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: "vs. NAC + OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   827   C0028929:Oleic Acid [Lipid]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]
   734   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine

Phrase: "and"

Phrase: "P < 0.05 for OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C0028929:Oleic Acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "vs. NAC + OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   827   C0028929:Oleic Acid [Lipid]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]
   734   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine

Phrase: "; n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.105: Insulin content in MIN6 cells treated with NAC alone was not significantly different from that of control cells (16.4  2.2 ng insulin/g DNA compared with 12.7  1.16 ng insulin/g DNA, P = 0.19; n = 5). 

Phrase: "Insulin content in MIN6 cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   781   C0030281:Insulin Cell [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "treated with NAC"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   858   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   790   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "not significantly different from that of control cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "(16.4  2.2 ng insulin/g DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "compared with 12.7  1.16 ng insulin/g DNA,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   757   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C1334110:NG.1 [Gene or Genome]
   757   C1627892:ng/g [Quantitative Concept]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0439267:g% [Quantitative Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1707455:Compared [Activity]

Phrase: "P = 0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.106: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.107: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.108: Effect of 72 h of OA and/or NAC treatment of MIN6 cells on basal and GSIS and insulin content. 

Phrase: "Effect of 72 h of OA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "NAC treatment of MIN6 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "on basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin content."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.109: A: Insulin was measured in the media following incubation of MIN6 cells in 0 mmol/l glucose or concentrations increasing incrementally from 3 to 30 mmol/l. 

Phrase: "A"

Phrase: ":"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in the media"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0444706:Measured [Qualitative Concept]
   770   C1254021:Media [Tissue]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation of MIN6 cells"

Phrase: "in 0 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "incrementally from 3"

Phrase: "to 30 mmol/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]
Processing 00000000.tx.110: Insulin secretion is reported as the fold change over basal insulin secretion (BSA control). 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "reported as the fold change over basal insulin secretion"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   764   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C1256369:insulin secretion [Cell Function]
   764   C1880833:Fold Change [Quantitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0205112:Basal [Spatial Concept]
   742   C0332462:Fold [Spatial Concept]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1705241:Change [Quantitative Concept]
   742   C1880834:FOLD [Phenomenon or Process]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]

Phrase: "(BSA control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.111: Results are the mean of three separate experiments performed in duplicate (SE). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean of three separate experiments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(SE"

Phrase: ")."
Processing 00000000.tx.112: *P < 0.05 for OA vs. 

Phrase: "*P < 0.05 for OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C0028929:Oleic Acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.113: BSA and ^P < 0.05 for OA + NAC vs. 

Phrase: "BSA"

Phrase: "and ^"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "for OA + NAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "vs."
Processing 00000000.tx.114: BSA. 

Phrase: "BSA."
Processing 00000000.tx.115: B: Total cellular insulin was acid/ethanol extracted from MIN6 cells and quantified by insulin radioimmunoassay. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Total cellular insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "acid/ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "extracted from MIN6 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   770   C3541890:EXTRACTED [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "quantified by insulin radioimmunoassay."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0034580:Radioimmunoassay [Laboratory Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C1709793:Quantify [Quantitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.116: Results were normalized to insulin per microgram DNA. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "normalized to insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1882115:Normalized [Research Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "per microgram DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.117: Results are means of five separate experiments performed in duplicate (SE).  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "means of five separate experiments"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(SE"

Phrase: ")."
Processing 00000000.tx.118: ROS production induced by OA and/or NAC in MIN6 cells. 

Phrase: "ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "induced by OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205263:Induced [Functional Concept]

Phrase: "and/or"

Phrase: "NAC in MIN6 cells."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   853   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   778   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   774   C0347983:cells/L [Quantitative Concept]
   757 E C0022827:cell l [Cell]
Processing 00000000.tx.119: Preliminary experiments suggested that the mitochondrial respiratory chain is the principal source of ROS in MIN6 cells (data not shown). 

Phrase: "Preliminary experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mitochondrial respiratory chain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1325653:mitochondrial respiratory chain [Cell Component]
           respiratory chain
   901   C0162362:Respiratory Chain [Molecular Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0337112:Chain [Manufactured Object]
   827   C0521346:respiratory [Functional Concept]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1524075:Chain [Idea or Concept]
   827   C1546767:Respiratory [Intellectual Product]

Phrase: "is"

Phrase: "the principal source of ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449416:Source [Finding]
   748   C1705919:Source [Idea or Concept]

Phrase: "in MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: Total hydrogen peroxide production in mitochondrial respiratory complexes I and III was measured in MIN6 cells. 

Phrase: "Total hydrogen peroxide production in mitochondrial respiratory complexes I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "was"

Phrase: "measured in MIN6 cells."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C3282337:Cells [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.121: OA increased ROS production by 2.6-fold (P < 0.001 for OA vs. BSA), which importantly was prevented by the addition of NAC (P = 0.07 for OA + NAC vs. BSA) (Fig. 2). 

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "ROS production by 2.6-fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]

Phrase: "(P < 0.001 for OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C0028929:Oleic Acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "vs. BSA"

Phrase: ")"

Phrase: ","

Phrase: "which importantly"

Phrase: "was"

Phrase: "prevented by the addition of NAC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   764   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   742   C1883712:Addition [Functional Concept]
   708   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(P = 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "for OA + NAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "vs. BSA) (Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.122: NAC alone did not significantly change the ROS production compared with BSA control. 

Phrase: "NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "compared with BSA control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.123: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.125: The effects of OA on ROS production. 

Phrase: "The effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on ROS production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.126: The cells were treated with 0.4 mmol/l OA bound to 0.5% BSA in the presence or absence of 1 mmol/l NAC for 72 h (n = 4).  

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0.4 mmol/l OA"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0028929:Oleic Acid [Lipid]
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439190:MMOLE [Quantitative Concept]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "bound to 0.5% BSA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0444499:0/5 [Quantitative Concept]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 1 mmol/l NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 72 h (n = 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.127: The effects of OA and/or NAC on global gene expression in MIN6 cells. 

Phrase: "The effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "NAC on global gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   770   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "in MIN6 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.128: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.129: 3A, of the 12,500 genes or ESTs analyzed by gene microarray, OA decreased expression of 845, 653, 529, or 639 genes or ESTs in four independent microarray analyses. 

Phrase: "3A,"

Phrase: "of the 12,500 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "or"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "analyzed by gene microarray,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1522053:Gene Microarray [Molecular Biology Research Technique]
   770   C0017337:Gene [Gene or Genome]
   770   C0936012:Analyzed [Research Activity]
   770   C1709016:Microarray [Manufactured Object]

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "expression of 845,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "653,"

Phrase: "529,"

Phrase: "or"

Phrase: "639 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "or"

Phrase: "ESTs in four independent microarray analyses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.130: Changes in gene expression were identified as being increased or decreased by comparing treatment to BSA control using Microarray Suite 5.0. 

Phrase: "Changes in gene expression"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "being"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "or"

Phrase: "decreased by comparing treatment"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0547047:Decrease [Quantitative Concept]
   737   C1707455:Compare [Activity]

Phrase: "to BSA control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Microarray Suite 5.0."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1553446:Suite [Intellectual Product]
   812   C1709016:Microarray [Manufactured Object]
Processing 00000000.tx.131: Coincubation with NAC markedly reduced the number of OA-downregulated genes or ESTs from 667  66 to 192  29 (P < 0.05 for OA vs. OA + NAC). 

Phrase: "Coincubation with NAC markedly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the number of OA-downregulated genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0546742:Acid number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "ESTs from 667  66"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to 192  29"

Phrase: "(P < 0.05 for OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C0028929:Oleic Acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "vs. OA + NAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ")."
Processing 00000000.tx.132: The number of upregulated genes and ESTs was not significantly reduced (265  88 to 212  44, P = 0.77 for OA vs. OA + NAC). 

Phrase: "The number of upregulated genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(265  88 to 212  44,"

Phrase: "P = 0.77 for OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C0028929:Oleic Acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "vs. OA + NAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ")."
Processing 00000000.tx.133: NAC independently upregulated 240 and downregulated 160 genes and ESTs. 

Phrase: "NAC independently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   937   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   840   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "upregulated"

Phrase: "240"

Phrase: "and"

Phrase: "downregulated"

Phrase: "160 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "ESTs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.134: View larger version (35K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.135: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.136: A: Effects of OA on global gene expression in MIN6 cells. 

Phrase: "A"

Phrase: ":"

Phrase: "Effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on global gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in MIN6 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.137: Number of changed genes or ESTs was evaluated (increased or decreased) by comparing test conditions to BSA control by Microarray Suite 5.0 (n = 4). 

Phrase: "Number of changed genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "or"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "("

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "or"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: "by comparing test conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0449910:Test conditions [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "to BSA control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "by Microarray Suite 5.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1553446:Suite [Intellectual Product]
   812   C1709016:Microarray [Manufactured Object]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: B: The distribution of OA-regulated genes into functional clusters. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "The distribution of OA-regulated genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "into functional clusters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555715:Cluster [Idea or Concept]
   827   C1704332:Cluster [Quantitative Concept]
Processing 00000000.tx.139: A total of 45 of OA-regulated genes confirmed by both microarray and real-time PCR were classified by function. 

Phrase: "A total of 45 of OA-regulated genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]

Phrase: "confirmed by both microarray"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   770   C1709016:Microarray [Manufactured Object]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "real-time PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "were"

Phrase: "classified by function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0008902:Classified [Classification]
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   718 E C0205245:Functional [Functional Concept]
   718 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.140: Number in parentheses indicates number of genes in category. 

Phrase: "Number in parentheses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "indicates"

Phrase: "number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "in category."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683312:Category [Intellectual Product]
  1000   C1555713:category [Idea or Concept]
Processing 00000000.tx.141: MIN6 cells were exposed to 0.4 mmol/l OA bound to 0.5% BSA, in the presence or absence of 1 mmol/l NAC or NAC alone for 72 h before any experiment.  

Phrase: "MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 0.4 mmol/l OA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0028929:Oleic Acid [Lipid]
   770   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439190:MMOLE [Quantitative Concept]

Phrase: "bound to 0.5% BSA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0444499:0/5 [Quantitative Concept]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 1 mmol/l NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "alone for 72 h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "before any experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.142: Analyses of microarray results revealed that the expression of 62 genes was consistently regulated by OA from three to four independent experiments (Table 1). 

Phrase: "Analyses of microarray results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1449575:Microarray Analysis [Laboratory Procedure]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the expression of 62 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "consistently"

Phrase: "regulated by OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "from three to four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.143: To verify OA-regulated expression of genes detected with microarray, these 62 genes were further characterized by real-time PCR. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "OA-regulated expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "detected with microarray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1709016:Microarray [Manufactured Object]

Phrase: "these 62 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterized by real-time PCR."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   806   C1550177:Real Time [Idea or Concept]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040223:Time [Temporal Concept]
   760   C0237400:Real [Qualitative Concept]
   760   C0677874:pCR [Finding]
   760   C1880022:Characterized [Activity]
   760   C3272377:REAL [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.144: A total of 45 of 62 (73%) of the genes deemed significantly changed by the microarray analysis were further confirmed by real-time PCR (Tables 1 and 2). 

Phrase: "A total of 45 of 62"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "(73%"

Phrase: ")"

Phrase: "of the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "deemed"

Phrase: "significantly"

Phrase: "changed by the microarray analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1449575:Microarray Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392747:Changed [Functional Concept]
   760   C0443172:Changed [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1709016:Microarray [Manufactured Object]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed by real-time PCR (Tables 1"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0039224:tables [Manufactured Object]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1706074:Tables [Intellectual Product]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.145: PCR confirmed all 16 genes changed by >1.8-fold, and the majority of the genes (28 of 38) shown to be changed between 1.4- to 1.7-fold, in microarray analysis. 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "all 16 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "changed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0392747:Changed [Functional Concept]
   833   C0443172:Changed [Quantitative Concept]
   799 E C1705241:Change [Quantitative Concept]

Phrase: ">1.8-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "the majority of the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "(28 of 38"

Phrase: ")"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "changed between 1.4-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "to 1.7-fold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C3541329:1-7 [Gene or Genome]

Phrase: "in microarray analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1449575:Microarray Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.146: In contrast, only one of the eight genes that changed between 1.2- to 1.3-fold in the microarray was also found to be upregulated through RT-PCR analysis (Table 2B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "only one of the eight genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "changed between 1.2-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "to 1.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "in the microarray"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709016:Microarray [Manufactured Object]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "upregulated through RT-PCR analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0200931:PCR analysis [Laboratory Procedure]
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(Table 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.147: View this table: [in this window] [in a new window]  TABLE 1 Regulation of genes by OA in the presence or absence of NAC analyzed by microarray or real-time PCR  View this table: [in this window] [in a new window]  TABLE 2 Effects of NAC on the number of genes or ESTs consistently regulated by OA in at least three of four independent microarrays clustered according to function or fold of change.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Regulation of genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0017263:genes regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "analyzed by microarray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0936012:Analyzed [Research Activity]
   790   C1709016:Microarray [Manufactured Object]

Phrase: "or"

Phrase: "real-time PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Effects of NAC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "or"

Phrase: "ESTs consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "regulated by OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "in"

Phrase: "at least three"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205449:Three [Quantitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of four independent microarrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709016:Microarray [Manufactured Object]

Phrase: "clustered according to function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0680240:according [Social Behavior]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   737   C1555715:Cluster [Idea or Concept]
   737   C1704332:Cluster [Quantitative Concept]

Phrase: "or"

Phrase: "fold of change."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1880833:Fold Change [Quantitative Concept]
   790   C0332462:Fold [Spatial Concept]
   790   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.148: OA-regulated genes were clustered according to known function (Table 1 and Fig. 3B). 

Phrase: "OA-regulated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "clustered according to known function"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0031843:function [Physiologic Function]
   760   C0205309:Known [Qualitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.149: The effects of NAC on the normalization of OA-regulated genes are shown in Table 1 and summarized in Table 2. 

Phrase: "The effects of NAC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on the normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "of OA-regulated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "shown in Table 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.150: Genes involved in metabolism comprised the largest functional cluster with 32% (14 of 45) of genes classified in this group. 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025519:Metabolism [Organism Function]
   790   C0025520:metabolism [Functional Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "comprised"

Phrase: "the largest functional cluster with 32%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1555715:Cluster [Idea or Concept]
   753   C1704332:Cluster [Quantitative Concept]

Phrase: "(14 of 45"

Phrase: ")"

Phrase: "of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "classified in this group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0008902:Classified [Classification]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
Processing 00000000.tx.151: OA significantly upregulated genes involved in -oxidation of lipids including carnitine palmitoyltransferase 1 (4.0  0.85-fold), 3-ketoacyl-CoA thiolase homolog (3.4  0.59-fold), long-chain acyl-CoA dehydrogenase (1.9  0.07-fold), and solute carrier family 25 member 20/mCAC (2.7  0.38-fold), as well as genes involved in carbohydrate metabolism, such as fructose bisphosphatase-1 (2.0  0.11-fold) and mannosidase-1 (2.4  0.32-fold). 

Phrase: "OA significantly upregulated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017337:Genes [Gene or Genome]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -oxidation of lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C2612546:lipid oxidation [Molecular Function]
   770   C0030011:Oxidation [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "carnitine palmitoyltransferase 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007262:Carnitine palmitoyltransferase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Carnitine Palmitoyltransferase
  1000   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   827   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(4.0  0.85-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "3-ketoacyl-CoA thiolase homolog"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1334043:Homolog [Gene or Genome]
   771   C0001021:3-Ketoacyl CoA Thiolase [Amino Acid, Peptide, or Protein,Enzyme]
   704 E C2697616:Homology [Qualitative Concept]

Phrase: "(3.4  0.59-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "long-chain acyl-CoA dehydrogenase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0065170:Long-Chain-Acyl-CoA Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1439272:ACYL-CoA DEHYDROGENASE, LONG-CHAIN [Gene or Genome]
   884   C0050688:acyl-CoA dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0085744:Acyl-CoA dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
           Acyl dehydrogenase
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(1.9  0.07-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "solute carrier family 25 member 20/mCAC"

Phrase: "(2.7  0.38-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in carbohydrate metabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0302820:Carbohydrate Metabolism [Molecular Function]
   770   C0007004:Carbohydrate [Carbohydrate]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "such as fructose bisphosphatase-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0016755:Fructose-Bisphosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]

Phrase: "(2.0  0.11-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "mannosidase-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024746:Mannosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(2.4  0.32-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.152: In contrast, OA downregulated stearoyl-CoA desaturase (SCD)-1 (-5.1  0.03-fold) and SCD2 (-2.7  0.04-fold), which encode proteins involved in the synthesis of unsaturated fatty acids, as well as the gene encoding an electron transporter NAD(P)H dehydrogenase (-2.2  0.04-fold). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "OA downregulated stearoyl-CoA desaturase (SCD)-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0038233:Stearoyl-CoA Desaturase [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1419846:STEAROYL-CoA DESATURASE [Gene or Genome]
   818   C0075202:stearoyl-CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0599871:desaturase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(-5.1  0.03-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "SCD2"

Phrase: "(-2.7  0.04-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in the synthesis of unsaturated fatty acids,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C2263126:unsaturated fatty acid synthesis [Molecular Function]
   800   C0015690:Fatty Acids, Unsaturated [Lipid]
   776   C0596562:fatty acid synthesis [Molecular Function]
   770   C0015684:Fatty Acids [Lipid]
   744   C0001128:Acids [Chemical]
   744   C0220781:synthesis [Biologic Function]
   744   C0522535:Unsaturated [Quantitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1883254:Synthesis [Activity]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "as well as"

Phrase: "the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "an electron transporter NAD(P)H dehydrogenase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0068341:NAD(P)H dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1151383:NAD(P)H dehydrogenase [Molecular Function]
   799   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(-2.2  0.04-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.153: Importantly, all genes in the metabolism cluster differentially regulated by OA were not normalized by NAC treatment (Tables 1 and 2). 

Phrase: "Importantly,"

Phrase: "all genes in the metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "cluster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555715:Cluster [Idea or Concept]
  1000   C1704332:Cluster [Quantitative Concept]

Phrase: "differentially"

Phrase: "regulated by OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "normalized by NAC treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   835   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   778   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1882115:Normalized [Research Activity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(Tables 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.154: Genes clustered into cell growth/differentiation and signal transduction groups represent 13% (6 of 45) and 16% (7 of 45) of the clustered genes, respectively. 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "clustered into cell growth/differentiation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   806   C0007595:Cell Growth [Cell Function]
   797   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   781   C1179412:Cell cluster [Body Part, Organ, or Organ Component]
   760   C0007634:Cell [Cell]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1269647:Cell [Cell]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2911660:Growth [Activity]
   760   C2945687:Differentiation [Functional Concept]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "signal transduction groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0037083:Signal Transduction [Cell Function]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "13%"

Phrase: "(6 of 45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C1627364:6/45 [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "16%"

Phrase: "(7 of 45"

Phrase: ")"

Phrase: "of the clustered genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.155: OA downregulated all the genes involved in cell growth and differentiation, all of which were normalized by coincubation with NAC. 

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "downregulated"

Phrase: "all the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "normalized by coincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "with NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.156: OA increased the expression of signal transduction genes encoding JNK3/MAPK10 (1.8  0.10-fold) and a calcium sensor protein, visinin-like protein (VILIP)-1 (2.2  0.07-fold), while decreasing the expression of genes encoding protein phosphatase 1 regulatory subunit 1A (-1.8  0.04-fold). 

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of signal transduction genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "JNK3/MAPK10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334478:MAPK10 [Gene or Genome]
   861   C1455843:MAPK10 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1.8  0.10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "a calcium sensor protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0805431:Calcium/Protein [Quantitative Concept]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "visinin-like protein (VILIP)-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]
   923   C1421472:VISININ-LIKE 1 [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2.2  0.07-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "protein phosphatase 1 regulatory subunit 1A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0450344:1A [Intellectual Product]
   799   C1553633:1a [Medical Device]
   709   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]

Phrase: "(-1.8  0.04-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.157: The addition of NAC failed to normalize most of the genes (86%, 6 of 7) mediating signal transduction. 

Phrase: "The addition of NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "most of the genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Genes [Gene or Genome]
   770   C0205393:Most [Quantitative Concept]

Phrase: "(86%,"

Phrase: "6 of 7"

Phrase: ")"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.158: OA also regulated several genes involved in transcription, protein trafficking and secretion, nucleosome assembly, and cellular defense response, comprising 29% (14 of 45) of the clustered genes (Fig. 3B). 

Phrase: "OA also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   901   C0028929:Oleic Acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "several genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "involved in transcription,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040649:Transcription [Genetic Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "nucleosome assembly,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156189:nucleosome assembly [Genetic Function]
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "cellular defense response,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155076:cellular defence response [Cell Function]
   901   C1154988:defence response [Organism Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "comprising"

Phrase: "29%"

Phrase: "(14 of 45"

Phrase: ")"

Phrase: "of the clustered genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.159: In particular, the Sdf-1 gene (2.8  0.51-fold) was significantly upregulated in response to OA, effects not reversed by NAC. 

Phrase: "In particular,"

Phrase: "the Sdf-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C1861886:CELL Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]
   780   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   780   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]

Phrase: "(2.8  0.51-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "was"

Phrase: "significantly"

Phrase: "upregulated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to OA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reversed by NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   790   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   719   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.160: Conversely, as shown on Table 2, 30 of the OA-regulated genes or ESTs were normalized by the addition of NAC in microarray analysis. 

Phrase: "Conversely,"

Phrase: "as"

Phrase: "shown on Table 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "30 of the OA-regulated genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   778   C0028929:Oleic Acid [Lipid]
   748   C0001128:Acid [Chemical]
   748   C0017337:Genes [Gene or Genome]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "normalized by the addition of NAC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   764   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   742   C1882115:Normalized [Research Activity]
   742   C1883712:Addition [Functional Concept]

Phrase: "in microarray analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1449575:Microarray Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.161: Among them, real-time PCR confirmed 13 NAC-normalized genes. 

Phrase: "Among them,"

Phrase: "real-time PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "13 NAC-normalized genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.162: PCR confirmed that most of NAC-normalized genes were involved in the cell growth/differentiation functional group, while most of genes involved in metabolism group could not be reversed by NAC (Tables 1 and 2). 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that most of NAC-normalized genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   764   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   742   C0017337:Genes [Gene or Genome]
   742   C1882115:Normalized [Research Activity]

Phrase: "were"

Phrase: "involved in the cell growth/differentiation functional group,"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   770   C0007595:Cell Growth [Cell Function]
   770   C0598132:functional group [Chemical Viewed Functionally]
   767   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   767   C2752631:functional differentiation [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205245:Functional [Functional Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0441833:Group [Idea or Concept]
   744   C0542341:Functional [Functional Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1269647:Cell [Cell]
   744   C1314939:Involved [Functional Concept]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1552516:Group [Health Care Related Organization]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704653:Cell [Medical Device]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C1948049:Cell [Spatial Concept]
   744   C2700217:Functional [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C2945687:Differentiation [Functional Concept]

Phrase: "while"

Phrase: "most of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017337:Genes [Gene or Genome]
   790   C0205393:Most [Quantitative Concept]

Phrase: "involved in metabolism group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1314939:Involved [Functional Concept]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "reversed by NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   790   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   719   C1555029:Reverse [Idea or Concept]

Phrase: "(Tables 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.163: Kinase expression profiling in MIN6 cells. 

Phrase: "Kinase expression profiling in MIN6 cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1513400:Expression Profiling [Molecular Biology Research Technique]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]
Processing 00000000.tx.164: Kinexus kinase analysis detected 46 of 75 screened kinases and 19 of 36 screened phosphorylated protein kinases at or above a TQ of 2,000, which is considered to be the threshold for detection (Table 3A and B). 

Phrase: "Kinexus kinase analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "46 of 75 screened kinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   726   C0220908:screen [Health Care Activity]
   726   C1305399:screen [Functional Concept]
   726   C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "19 of 36"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "phosphorylated protein kinases at"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or above a TQ of 2,000,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0442822:Trace [Quantitative Concept]
   744   C1265611:Quantity [Quantitative Concept]
   744   C1524031:Trace [Qualitative Concept]
   744   C1554108:Quantity [Intellectual Product]
   744   C1561573:Quantity [Intellectual Product]
   744   C1883002:Trace [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the threshold for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449864:Threshold [Qualitative Concept]

Phrase: "(Table 3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.165: The expression levels of several kinase proteins correlated positively with a screen of TC-3 and INS-1 cell lines (32) (Table 3A). 

Phrase: "The expression levels of several kinase proteins"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "positively with a screen of TC-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0041405:TC [Geographic Area]
   748   C0220908:screen [Health Care Activity]
   748   C1305399:screen [Functional Concept]
   748   C1705053:Screen [Medical Device]
   748   C1824670:TC [Gene or Genome]
   748   C3272447:TC [Gene or Genome]

Phrase: "and INS-1 cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0007600:Cell lines [Cell]
   806   C1414685:INS-1 [Gene or Genome]
   806   C3538717:INS-1 [Gene or Genome]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "(Table 3A"

Phrase: ")."
Processing 00000000.tx.166: Kinases comprising the three MAPK modules, Raf1/BMAPK (MEK) 1/2extracellular regulated kinase (Erk) 1/2, Cancer Osaka thyroid oncogene (COT)MEK 4/7JNK, and p21 activated kinase (PAK) 1MEK6p38 MAPK were detected in MIN6 cells. 

Phrase: "Kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "comprising"

Phrase: "the three MAPK modules,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1709061:Module [Conceptual Entity]
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Raf1/BMAPK"

Phrase: "(MEK) 1/2extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1434639:MEK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Erk) 1/2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Cancer Osaka thyroid oncogene (COT)MEK 4/7JNK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   710   C1337108:CANCER OSAKA THYROID ONCOGENE [Gene or Genome]
   710   C1705156:Cancer Osaka Thyroid Oncogene [Gene or Genome]

Phrase: "and"

Phrase: "p21 activated kinase (PAK) 1MEK6p38 MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   807   C1955933:p21-Activated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "detected in MIN6 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.167: Kinases involved in phosphatidylinositol 3-kinase signaling pathways, 3-phosphoinositide-dependent protein kinase (PDK) 1protein kinase B (PKB)glycogen synthase kinase (GSK) 3 or S6K p70 were also present. 

Phrase: "Kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in phosphatidylinositol 3-kinase signaling pathways,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   814   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   786 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0037080:pathways signaling [Molecular Function]
   762 E C0037083:signaling pathway [Cell Function]
           Signaling
   762 E C0086982:Signaling Pathway [Molecular Function]
   748   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1314939:Involved [Functional Concept]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
   748   C2348046:Phosphatidylinositol [Lipid]
   748   C3537152:signaling [Biologic Function]
   714 E C1710082:Signal [Phenomenon or Process]

Phrase: "3-phosphoinositide-dependent protein kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0538677:3-phosphoinositide-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PDK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1150639:PDK [Molecular Function]

Phrase: ")"

Phrase: "1protein kinase B (PKB"

Phrase: ")"

Phrase: "glycogen synthase kinase (GSK) 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "S6K p70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0753627:P70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1705582:P70 [Gene or Genome]
   861   C1836606:p70 [Gene or Genome]

Phrase: "were"

Phrase: "also"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.168: Multiple isoforms of PKC (-, -, -, and -), including atypical isoform PKC- and cell cycle-regulating cyclin-dependent kinases (Cdk2, 4, 5, 6, and 7) were also detected by the kinase protein screening. 

Phrase: "Multiple isoforms of PKC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "(-, -"

Phrase: ", -"

Phrase: ","

Phrase: "and -"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atypical isoform PKC-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   933   C0758621:atypical protein kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   853   C1168438:Protein C [Laboratory Procedure]
   853   C1418943:PROTEIN C [Gene or Genome]
   853   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cell cycle-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "regulating"

Phrase: "cyclin-dependent kinases"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243045:Cyclin-Dependent Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1150565:cyclin [Molecular Function]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "(Cdk2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108855:CDK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332733:CDK2 [Gene or Genome]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "detected by the kinase protein screening."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0033640:kinase protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220908:Screening [Health Care Activity]
   753   C0220909:screening [Functional Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1698960:screening [Intellectual Product]
   753   C1710031:Screening [Diagnostic Procedure]
   753   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.169: We detected v-mos Moloney murine sarcoma viral oncogene homolog (MOS1) kinase, which had not been previously described in pancreatic -cells. 

Phrase: "We"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "v-mos Moloney murine sarcoma viral oncogene homolog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026574:V-MOS MOLONEY MURINE SARCOMA VIRAL ONCOGENE HOMOLOG [Gene or Genome]
   793   C1334043:Homolog [Gene or Genome]
   717   C0080294:v-mos Oncogene [Gene or Genome]

Phrase: "(MOS1"

Phrase: ")"

Phrase: "kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "described in pancreatic -cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C1552738:described [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.170: Phosphorylation of specific epitopes on Raf1MEK1/2Erk 1/2, PKBGSK3, SrcSTAT3, and PKC-, -, - signaling molecules were detectable by the kinase phosphorylation screen (Table 3B). 

Phrase: "Phosphorylation of specific epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "on Raf1MEK1/2Erk 1/2,"

Phrase: "PKBGSK3,"

Phrase: "SrcSTAT3,"

Phrase: "and"

Phrase: "PKC-, -"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ", -"

Phrase: "signaling molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1519315:Signaling Molecule [Biologically Active Substance]
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "detectable by the kinase phosphorylation screen"

Phrase: "(Table 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.171: View this table: [in this window] [in a new window]  TABLE 3 Expression levels of protein kinase (A) and phosphoprotein kinases (B) in MIN6 cells  The effects of OA and/or NAC on protein kinase expression and phosphorylation in MIN6 cells. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Expression levels of protein kinase (A"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C1171362:expression protein [Genetic Function]
   750   C0428479:Protein level [Laboratory or Test Result]
   750   C0456949:Level 3 [Intellectual Product]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "phosphoprotein kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B) in MIN6 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0004561:B-Cells [Cell]
   770   C2347469:/B [Quantitative Concept]

Phrase: "The effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "NAC on protein kinase expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   770   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "and"

Phrase: "phosphorylation in MIN6 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.172: The effects of OA on the expression and the phosphorylation states of the protein kinases listed in Table 4 were assessed in MIN6 cells. 

Phrase: "The effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the phosphorylation states of the protein kinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1301808:states [Geographic Area]
   714 E C1442792:State [Functional Concept]
   714 E C3148680:State [Geographic Area]

Phrase: "listed in Table 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]

Phrase: "were"

Phrase: "assessed in MIN6 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1516048:Assessed [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.173: Kinase screen data showed that OA consistently regulated the expression of 10 protein kinases and the phosphorylation states of 3 protein kinases >1.25-fold (Table 4). 

Phrase: "Kinase screen data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that OA consistently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   901   C0028929:Oleic Acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "the expression of 10 protein kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the phosphorylation states of 3 protein kinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1301808:states [Geographic Area]
   714 E C1442792:State [Functional Concept]
   714 E C3148680:State [Geographic Area]

Phrase: ">1.25-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: Conventional Western blotting confirmed the OA-induced regulation of the protein level of six protein kinases (CDK7, GRK2, p38 MAPK, PKC-, JNK3/MAPK10, and p70S6K) and two of OA-induced changes in the phosphorylation states of kinases identified in the phospho-screen (p70S6K, Rb) (Table 4, Fig. 4). 

Phrase: "Conventional Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the OA-induced regulation of the protein level of six protein kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0851285:Regulation [Governmental or Regulatory Activity]
   735   C1327622:Regulation [Biologic Function]

Phrase: "(CDK7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413288:CDK7 [Gene or Genome]

Phrase: "GRK2,"

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "PKC-,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "JNK3/MAPK10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334478:MAPK10 [Gene or Genome]
   861   C1455843:MAPK10 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p70S6K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "two of OA-induced changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "in the phosphorylation states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "of kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "identified in the phospho-screen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205396:Identified [Qualitative Concept]
   760   C0220908:screen [Health Care Activity]
   760   C1305399:screen [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1705053:Screen [Medical Device]

Phrase: "(p70S6K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "Rb"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: ")"

Phrase: "(Table 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.175: Western blotting also demonstrated that the addition of NAC normalized OA-induced regulation of most of the kinases but not OA-regulated JNK3/MAPK10 and p70S6K protein levels or phosphorylated Rb levels. 

Phrase: "Western blotting also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the addition of NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "OA-induced regulation of most of the kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "but"

Phrase: "not OA-regulated JNK3/MAPK10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1334478:MAPK10 [Gene or Genome]
   799   C1455843:MAPK10 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p70S6K protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "phosphorylated Rb levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.176: Interestingly, both microarray and PCR data also show increased gene expression of JNK3/MAPK10 in OA-treated samples, effects not normalized by the addition of NAC. 

Phrase: "Interestingly,"

Phrase: "both microarray"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709016:Microarray [Manufactured Object]

Phrase: "and"

Phrase: "PCR data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "increased gene expression of JNK3/MAPK10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   783   C1334478:MAPK10 gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in OA-treated samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "normalized by the addition of NAC."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   764   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   742   C1882115:Normalized [Research Activity]
   742   C1883712:Addition [Functional Concept]
Processing 00000000.tx.177: NAC alone did not have a significant effect on these OA-regulated kinases. 

Phrase: "NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a significant effect on these OA-regulated kinases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.178: View this table: [in this window] [in a new window]  TABLE 4 Regulation of kinases by OA in the presence or absence of NAC analyzed by kinase screen or Western blotting  View larger version (95K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 4 Regulation of kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "analyzed by kinase screen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0220908:screen [Health Care Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1305399:screen [Functional Concept]
   770   C1705053:Screen [Medical Device]

Phrase: "or"

Phrase: "Western blotting  View larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0333052:Version [Functional Concept]
   804   C2607870:Version [Spatial Concept]

Phrase: "(95K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.179: 4. 

Phrase: "4."
Processing 00000000.tx.180: Protein levels of OA-regulated protein kinases and proteins. 

Phrase: "Protein levels of OA-regulated protein kinases"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441889:Levels [Qualitative Concept]
   737   C0428479:Protein level [Laboratory or Test Result]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.181: Confirmatory Western blots were performed on protein kinases found to be upregulated in the protein kinase screen, as well as two genes found to be significantly upregulated in microarray analysis, VILIP-1 and Sdf-1. 

Phrase: "Confirmatory Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0949466:Western Blots [Laboratory Procedure]
   867 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "performed on protein kinases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "upregulated in the protein kinase screen,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "as well as"

Phrase: "two genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significantly"

Phrase: "upregulated in microarray analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1449575:Microarray Analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1709016:Microarray [Manufactured Object]

Phrase: "VILIP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]
   923   C1421472:VISININ-LIKE 1 [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Sdf-1."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]
   840   C0162597:Stromal cell [Cell]
   804   C0007634:Cell [Cell]
   804 E C0596291:stroma cell [Cell Component]
   804   C1269647:Cell [Cell]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]
   733   C0927195:Stroma [Body Part, Organ, or Organ Component]
Processing 00000000.tx.182: Representative Western blots of three to six independent experiments are shown. 

Phrase: "Representative Western blots of three to six independent experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0949466:Western Blots [Laboratory Procedure]
   742   C1705493:Western [Spatial Concept]
   731 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.183: The fold change of these and other proteins identified in protein and gene profiling were analyzed by density scan and normalized with -actin protein as shown in Table 4.  

Phrase: "The fold change of these"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1880833:Fold Change [Quantitative Concept]
   797   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "identified in protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "gene profiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "were"

Phrase: "analyzed by density scan"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034606:Scan [Diagnostic Procedure]
   770   C0178587:density [Quantitative Concept]
   770   C0441633:Scan [Diagnostic Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "normalized with -actin protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1882115:Normalized [Research Activity]

Phrase: "as"

Phrase: "shown in Table 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.184: Effects of OA and NAC on insulin protein synthesis and stabilization. 

Phrase: "Effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "NAC on insulin protein synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   770   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   767   C1156639:cysteine synthesis [Molecular Function]

Phrase: "and"

Phrase: "stabilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.185: Our studies revealed that insulin content was decreased by OA and normalized by NAC treatment (Fig. 1B) without changes in insulin mRNA levels measured by microarray and real-time PCR (data not shown). 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "decreased by OA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "normalized by NAC treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   835   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   778   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1882115:Normalized [Research Activity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "without changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "measured by microarray"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1709016:Microarray [Manufactured Object]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "real-time PCR (data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]
   756   C1709846:Real-Time PCR [Molecular Biology Research Technique]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.186: This suggests that insulin content of MIN6 cells is regulated posttranscriptionally by OA and NAC. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin content of MIN6 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "posttranscriptionally by OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.187: To investigate the effects of OA and NAC on insulin protein synthesis at the posttranscriptional level, insulin content was measured after 36 h incubation of MIN6 cells with various combinations of CHX (an inhibitor of protein translation), OA, and NAC. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "NAC on insulin protein synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   770   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   767   C1156639:cysteine synthesis [Molecular Function]

Phrase: "at the posttranscriptional level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured after 36 h incubation of MIN6 cells"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   744   C0007634:Cells [Cell]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0444706:Measured [Qualitative Concept]
   744   C0564385:/h [Quantitative Concept]
   744   C3282337:Cells [Cell]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "with various combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0453882:Combinations [Manufactured Object]
   827 E C0205195:Combination [Qualitative Concept]
   827 E C1947911:Combination [Physical Object]

Phrase: "of CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "("

Phrase: "an inhibitor of protein translation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "OA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.188: A 36-h incubation was used because it showed the same pattern of alteration in insulin content as a 72-h incubation (Figs. 1B and 5). 

Phrase: "A 36-h incubation"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the same pattern of alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "in insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as a 72-h incubation"

Phrase: "(Figs. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.189: In control BSA-treated cells, a significant 60% decrease in insulin content was seen in the presence of CHX. 

Phrase: "In control BSA-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "a significant 60% decrease in insulin content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "seen in the presence of CHX."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   753   C0205397:Seen [Qualitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]
Processing 00000000.tx.190: In OA-treated cells, the results of three independent experiments demonstrated a trend toward decreased insulin content in the presence of CHX, but the difference was not significant (for BSA + CHX vs. OA + CHX, 3.9  0.6 vs. 2.3  0.2 ng insulin/g DNA, respectively, P = 0.11) (Fig. 5). 

Phrase: "In OA-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the results of three independent experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "demonstrated"

Phrase: "a trend toward decreased insulin content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of CHX,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "but"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "("

Phrase: "for BSA + CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   805 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "vs. OA + CHX,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   771 E C0947670:Actidione [Antibiotic,Organic Chemical]
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]

Phrase: "3.9  0.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0442759:3 6 [Finding]
   861   C0442760:3/9 [Finding]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "vs. 2.3  0.2 ng insulin/g DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "respectively,"

Phrase: "P = 0.11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0069877:P 11 [Organic Chemical,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.191: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.192: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.193: Posttranscriptional effects of OA and NAC on insulin content. 

Phrase: "Posttranscriptional effects of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "NAC on insulin content."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   778   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.194: MIN6 cells were treated with BSA only, OA-BSA, OA-BSA + NAC, and NAC + BSA in the presence or absence of 5 mol/l CHX, an inhibitor of protein translation. 

Phrase: "MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with BSA only,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0205171:Only [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   770   C1720467:Only [Intellectual Product]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "OA-BSA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]

Phrase: "OA-BSA + NAC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   818   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "and"

Phrase: "NAC + BSA in the presence"

Phrase: "or"

Phrase: "absence of 5 mol/l CHX,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "an inhibitor of protein translation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.195: Data shown represents mean  SE (n = 3). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean  SE (n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0444504:Mean [Quantitative Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.196: aP < 0.05 for OA vs. 

Phrase: "aP < 0.05 for OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   790   C0028929:Oleic Acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "vs."
Processing 00000000.tx.197: BSA, bP < 0.05 for OA + NAC vs. 

Phrase: "BSA,"

Phrase: "bP < 0.05"

Phrase: "for OA + NAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0001047:Acetyl cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "vs."
Processing 00000000.tx.198: OA, and cP < 0.05 for OA + NAC + CHX vs. 

Phrase: "OA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "cP < 0.05"

Phrase: "for OA + NAC + CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   740 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "vs."
Processing 00000000.tx.199: OA + CHX.   

Phrase: "OA + CHX."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   771 E C0947670:Actidione [Antibiotic,Organic Chemical]
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]
Processing 00000000.tx.200: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  In this study, we investigated the long-term effects of OA on MIN6 -cell function. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the long-term effects of OA"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C0023983:Long-Term Effects [Phenomenon or Process]
   778   C0443252:Long-term [Temporal Concept]
   748   C0205166:Long [Qualitative Concept]
   748   C1280500:effects [Qualitative Concept]
   748   C1515273:Term [Temporal Concept]
   748   C1705313:Term [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2826302:TERM [Intellectual Product]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on MIN6 -cell function."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.201: In agreement with previous studies in islets and other -cell lines (33,34), our results demonstrate that long-term exposure of MIN6 cells to OA leads to a threefold increase in basal insulin secretion with an inhibition of GSIS, and a greater than twofold increase in ROS. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "in islets"

Phrase: "and"

Phrase: "other -cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that long-term exposure of MIN6 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]

Phrase: "to OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "leads to a threefold increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0442805:Increase [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in basal insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with an inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of GSIS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a greater than twofold increase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "in ROS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.202: They are thought to contribute to the deterioration of islet function in the -cell (24,35,36), and antioxidants such as NAC and a combination of vitamins E and C can restore to some degree the ROS-mediated effects of glucotoxicity in -cells (24,25). 

Phrase: "They"

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the deterioration of islet function"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C0868945:Deterioration [Phenomenon or Process]
   748   C1705273:Function [Intellectual Product]
   748   C1880177:Contribute [Activity]

Phrase: "in the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "(24,"

Phrase: "35,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "antioxidants such as NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "and"

Phrase: "a combination of vitamins E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "C"

Phrase: "can"

Phrase: "restore to some degree"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "the ROS-mediated effects of glucotoxicity in -cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.203: However, in our studies, although ROS was elevated by OA and normalized by the addition of NAC, it failed to restore GSIS following OA treatment. 

Phrase: "However,"

Phrase: "in our studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "although"

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "was"

Phrase: "elevated by OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "normalized by the addition of NAC,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   764   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   742   C1882115:Normalized [Research Activity]
   742   C1883712:Addition [Functional Concept]

Phrase: "it"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "restore"

Phrase: "GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "OA treatment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]
Processing 00000000.tx.204: This suggests that the increase in ROS production associated with chronic OA treatment of -cells may not be directly implicated in the lipotoxic effects of OA on GSIS. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increase in ROS production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "associated with chronic OA treatment of -cells"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   770   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0028929:Oleic Acid [Lipid]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   750   C0699040:cell associated [Cell Component]
   744   C0001128:Acid [Chemical]
   744   C0007634:Cells [Cell]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0205191:chronic [Temporal Concept]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3282337:Cells [Cell]
   744   C3538994:TREATMENT [Research Activity]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "implicated in the lipotoxic effects of OA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   770   C0028929:Oleic Acid [Lipid]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on GSIS."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.205: The exact pathophysiology of lipotoxicity is as yet unclear, however a number of hypotheses have been proposed: 1) increased FFA oxidation with a concomitant decrease in glucose metabolism resulting from substrate competition (14), 2) increased production of intermediate metabolites and triglycerides from FFA esterification (33,37), and 3) increased expression of mitochondrial uncouplers in -cells (16,17,33). 

Phrase: "The exact pathophysiology of lipotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031847:pathophysiology [Functional Concept]
   760   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "is as yet unclear, however"

Phrase: "a number of hypotheses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "increased FFA oxidation with a concomitant decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030011:Oxidation [Molecular Function]

Phrase: "in glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "resulting from substrate competition"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0678226:resulting [Functional Concept]
   770   C0679932:competition [Social Behavior]
   770   C1710236:Substrate [Manufactured Object]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "increased production of intermediate metabolites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "triglycerides from FFA esterification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041004:Triglycerides [Biologically Active Substance,Lipid]

Phrase: "(33,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "increased expression of mitochondrial uncouplers in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(16,"

Phrase: "17,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.206: After prolonged exposure of MIN6 cells to OA, we have observed a significant upregulation of genes involved in -oxidation of lipids including carnitine palmitoyltransferase 1, 3-ketoacyl-CoA thiolase homolog, long-chain acyl-CoA dehydrogenase, and solute carrier family 25 member 20/mCAC. 

Phrase: "After prolonged exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
   861   C0439590:Prolonged [Temporal Concept]

Phrase: "of MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "to OA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significant upregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -oxidation of lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C2612546:lipid oxidation [Molecular Function]
   770   C0030011:Oxidation [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "carnitine palmitoyltransferase 1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007262:Carnitine palmitoyltransferase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Carnitine Palmitoyltransferase
  1000   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   827   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "3-ketoacyl-CoA thiolase homolog,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1334043:Homolog [Gene or Genome]
   771   C0001021:3-Ketoacyl CoA Thiolase [Amino Acid, Peptide, or Protein,Enzyme]
   704 E C2697616:Homology [Qualitative Concept]

Phrase: "long-chain acyl-CoA dehydrogenase,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0065170:Long-Chain-Acyl-CoA Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1439272:ACYL-CoA DEHYDROGENASE, LONG-CHAIN [Gene or Genome]
   884   C0050688:acyl-CoA dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0085744:Acyl-CoA dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
           Acyl dehydrogenase
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "solute carrier family 25 member 20/mCAC."
Processing 00000000.tx.207: In contrast, SCD1 and SCD2, which encode key rate-limiting enzymes involved in the synthesis of monounsaturated fatty acids (38,39), were significantly downregulated in response to OA treatment. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "SCD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419846:SCD1 [Gene or Genome]
  1000   C3540808:SCD1 [Gene or Genome]

Phrase: "and"

Phrase: "SCD2,"

Phrase: "which"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "key rate-limiting enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]

Phrase: "involved in the synthesis of monounsaturated fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C0015687:Fatty Acids, Monounsaturated [Biologically Active Substance,Lipid]
   776   C0596562:fatty acid synthesis [Molecular Function]
   770   C0015684:Fatty Acids [Lipid]
   744   C0001128:Acids [Chemical]
   744   C0220781:synthesis [Biologic Function]
   744   C1314939:Involved [Functional Concept]
   744   C1883254:Synthesis [Activity]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "(38,"

Phrase: "39"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "significantly"

Phrase: "downregulated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to OA treatment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]
Processing 00000000.tx.208: These findings imply that after long-term exposure to OA, OA-catabolic pathways are upregulated while the endogenous production of OA is inhibited in an effort to normalize the OA level. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "imply"

Phrase: "that"

Phrase: "after"

Phrase: "long-term exposure to OA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "OA-catabolic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "upregulated"

Phrase: "while"

Phrase: "the endogenous production of OA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "inhibited in an effort to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015264:Effort [Organism Function]
   760   C0311403:Inhibited [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the OA level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]
Processing 00000000.tx.209: Notably, the expression of genes involved in glycolysis and glucose oxidation was generally unchanged, in contrast with previous microarray studies (6,10). 

Phrase: "Notably,"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in glycolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017952:Glycolysis [Molecular Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "generally unchanged,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442739:Unchanged [Finding]
   861   C2346711:Unchanged [Qualitative Concept]

Phrase: "in contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "with previous microarray studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "(6,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.210: This may reflect differences in experimental protocol, such as the cell lines used, variations in glucose concentrations, or different incubation times with different FFAs. 

Phrase: "This"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "differences in experimental protocol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "such as the cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "variations in glucose concentrations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variations [Qualitative Concept]

Phrase: "or"

Phrase: "different incubation times with different FFAs."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   750   C0683585:free time [Daily or Recreational Activity]
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   714   C1442103:Time Difference [Temporal Concept]
   714   C1547049:*Time Difference [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.211: However, our study does support previous data that glucose oxidation is only minimally impaired by chronic exposure to elevated FFAs (40,41), suggesting that changes in glucose metabolism at the level of gene expression may not be an important effector of lipotoxicity in the -cells. 

Phrase: "However,"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "does"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "that glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "only minimally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "impaired by chronic exposure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205191:chronic [Temporal Concept]
   770   C0221099:Impaired [Functional Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   770   C0684336:Impaired [Pathologic Function]

Phrase: "to elevated FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that changes in glucose metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "an important effector of lipotoxicity"

Phrase: "in the -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.212: Prolonged exposure to FFAs inhibits insulin biosynthesis and posttranslational processing of proinsulin and results in decreased insulin content and insulin maturation in vivo and in vitro (5,9,15,42,43). 

Phrase: "Prolonged exposure to FFAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0439590:Prolonged [Temporal Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "posttranslational processing of proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "results in decreased insulin content"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0423896:Content [Mental Process]
   760   C0442797:decreased [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1274040:Result [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1546471:Result [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2825142:Result [Finding]
   726 E C0547047:Decrease [Quantitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9,"

Phrase: "15,"

Phrase: "42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.213: Our study showed that insulin content in MIN6 cells exposed to OA for 72 h was decreased 50% compared with that of control cells, and that this could be restored by cotreatment with NAC. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin content in MIN6 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "exposed to OA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "50%"

Phrase: "compared with that of control cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "could"

Phrase: "be"

Phrase: "restored by cotreatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0009429:cotreatment [Therapeutic or Preventive Procedure]
   790   C0814472:co-treatment [Health Care Activity]

Phrase: "with NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.214: The downregulation of insulin content by OA did not occur at the level of transcription, since both insulin I and insulin II mRNA levels were unchanged, as shown by both microarray analysis and real-time PCR (n = 3 independent studies, data not shown). 

Phrase: "The downregulation of insulin content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "by OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur at the level of transcription,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040649:Transcription [Genetic Function]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "since"

Phrase: "both insulin I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   972   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "insulin II mRNA levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0202098:insulin levels [Laboratory Procedure]
   902   C0428405:insulin levels [Laboratory or Test Result]
   858   C0441926:ii level [Intellectual Product]
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "unchanged,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "as"

Phrase: "shown by both microarray analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1449575:Microarray Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1709016:Microarray [Manufactured Object]
   726   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "real-time PCR (n = 3 independent studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   877   C0040227:Time Studies [Intellectual Product]
   801   C0681367:independent study [Educational Activity]
   795   C0947630:studies [Laboratory Procedure]
   762 E C0557651:Study [Manufactured Object]
   762 E C2603343:Study [Research Activity]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: This raises the possibility that modulation of insulin content by OA and NAC may occur at the posttranscriptional level. 

Phrase: "This"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that modulation of insulin content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "by OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "may"

Phrase: "occur at the posttranscriptional level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.216: This hypothesis is supported by experiments using CHX. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by experiments"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CHX."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]
Processing 00000000.tx.217: These studies revealed that inhibitors of protein translation modified in part the actions of OA and NAC. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that inhibitors of protein translation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "modified in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392747:Modified [Functional Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "the actions of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
Processing 00000000.tx.218: However, OA and NAC may also have translation-independent effects on insulin content by affecting posttranslation pathways and/or degradation of insulin. 

Phrase: "However,"

Phrase: "OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "NAC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "may"

Phrase: "also"

Phrase: "have"

Phrase: "translation-independent effects on insulin content"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0085862:Independent [Idea or Concept]
   753   C1280500:effects [Qualitative Concept]
   753   C1299583:Independent [Finding]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "by affecting posttranslation pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "and/or"

Phrase: "degradation of insulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
Processing 00000000.tx.219: An alternate pathway that could mediate the changes in insulin content is the mTOR/p70S6K pathway. 

Phrase: "An alternate pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3534339:alternate pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "could"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the changes in insulin content"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025320:The change [Physiologic Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "the mTOR/p70S6K pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.220: p70S6K is a kinase thought to control protein translation (44), and glucose-induced proinsulin biosythesis has been shown to be mediated through ATP modulation of mTOR/p70S6K pathway in MIN6 cells and islets (45). 

Phrase: "p70S6K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "is"

Phrase: "a kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to control protein translation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597295:Protein Translation [Molecular Function]
           translation
   812   C0040712:Translation [Intellectual Product]
   812   C1519614:Translation [Genetic Function]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "glucose-induced proinsulin biosythesis"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mediated through ATP modulation of mTOR/p70S6K pathway"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0443264:Modulation [Spatial Concept]
   744   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1307407:mTOR [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1414805:MTOR [Gene or Genome]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C2827383:p70S6K [Enzyme]

Phrase: "in MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "islets"

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.221: Our studies demonstrated that protein and phosphorylation levels of p70S6K were significantly diminished by OA treatment in MIN6 cells (Fig. 4, Table 4), an effect normalized by concomitant administration of NAC. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "phosphorylation levels of p70S6K"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "diminished by OA treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   806   C0028929:Oleic Acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0205216:Diminished [Quantitative Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "in MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "normalized by concomitant administration of NAC."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   807   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   764   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   742   C0001554:Administration [Occupational Activity]
   742   C0521115:Concomitant [Temporal Concept]
   742   C1533734:Administration [Therapeutic or Preventive Procedure]
   742   C1882115:Normalized [Research Activity]
Processing 00000000.tx.222: Thus, changes in p70S6K phosphorylation may also account for the reduced insulin content in OA-treated MIN6 cells, and its improvement by NAC. 

Phrase: "Thus,"

Phrase: "changes in p70S6K phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1705241:Change [Quantitative Concept]
   770   C2827383:p70S6K [Enzyme]

Phrase: "may"

Phrase: "also"

Phrase: "account for the reduced insulin content"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1551359:account [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "in OA-treated MIN6 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "its improvement by NAC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986411:Improvement [Conceptual Entity]
Processing 00000000.tx.223: In addition to effects on proinsulin synthesis, it has been suggested that activation of the mTOR/p70S6K pathway, independent of PDK1/PKB activation, is a key requirement for glucose-dependent -cell proliferation (46), consistent with the prominence of p70S6K in the control of protein translation. 

Phrase: "In addition to effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on proinsulin synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of the mTOR/p70S6K pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "independent of PDK1/PKB activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "a key requirement for glucose-dependent -cell proliferation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514873:Requirement [Functional Concept]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "consistent with the prominence of p70S6K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of protein translation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Translation [Molecular Function]
           translation
   861   C0040712:Translation [Intellectual Product]
   861   C1519614:Translation [Genetic Function]
Processing 00000000.tx.224: In our studies, genes and proteins involved in cell growth and survival showed a complex pattern of regulation in response to chronic OA treatment. 

Phrase: "In our studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a complex pattern of regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to chronic OA treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.225: In general, genes involved in cell cycle regulation, differentiation, and cell survival were downregulated in response to OA treatment, an effect reversed by NAC. 

Phrase: "In general, genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell cycle regulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1155872:Cell Cycle Regulation [Cell Function]
   812   C0851285:Regulation [Governmental or Regulatory Activity]
   812   C1327622:Regulation [Biologic Function]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "downregulated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to OA treatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0028929:Oleic Acid [Lipid]

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "reversed by NAC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0001047:l cysteine n acetyl [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   790   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine
   719   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.226: Given the importance of p70S6K in cell growth, and that OA suppresses p70S6K phosphorylation, lipid-induced suppression of p70S6K phosphorylation may be a key element in the failure to compensate for the -cell loss observed in lipotoxic environments. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the importance of p70S6K in cell growth,"

Phrase: "and"

Phrase: "that OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "p70S6K phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "lipid-induced suppression of p70S6K phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "may"

Phrase: "be"

Phrase: "a key element in the failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C1705248:Element [Conceptual Entity]

Phrase: "compensate for the -cell loss"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0205432:compensate [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1517945:Loss [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "observed in lipotoxic environments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014406:Environments [Spatial Concept]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.227: Conversely, a number of kinases involved in the stimulation of cell cycle regulation and cell growth are stimulated by OA-treatment, including CDK7 and Rb, suggesting compensatory stimulation of -cell growth in the face of elevated ROS and FFAs. 

Phrase: "Conversely,"

Phrase: "a number of kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "involved in the stimulation of cell cycle regulation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   822   C1155872:regulation of cell cycle [Cell Function]
           Cell Cycle Regulation
   770   C0007586:Cell Cycle [Cell Function]
   770   C1155839:Cell Cycle [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1269647:Cell [Cell]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1511572:Cycle [Temporal Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   744   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "are"

Phrase: "stimulated by OA-treatment,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   806   C0028929:Oleic Acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "CDK7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413288:CDK7 [Gene or Genome]

Phrase: "and"

Phrase: "Rb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "compensatory stimulation of -cell growth in the face of elevated ROS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   784   C2244506:stimulation of cell growth [Cell Function]
   763   C0007595:growth of cell [Cell Function]
           Cell Growth
   763   C2249825:stimulation of growth [Organism Function]
   735   C0018270:'growth' NOS [Organism Function]
   735   C0220844:growth [Physiologic Function]
   735   C1621966:Growth [Organ or Tissue Function]
   735   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "FFAs."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.228: The MAPK pathways are crucial to cell differentiation, proliferation, and survival. 

Phrase: "The MAPK pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "crucial to cell differentiation,"

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.229: We have confirmed the presence of three intact MAPK modules that have previously been detected in TC-3 and INS-1 cell lines (32). 

Phrase: "We"

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of three intact MAPK modules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "detected in TC-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0041405:TC [Geographic Area]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1824670:TC [Gene or Genome]
   770   C3272447:TC [Gene or Genome]

Phrase: "and INS-1 cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0007600:Cell lines [Cell]
   806   C1414685:INS-1 [Gene or Genome]
   806   C3538717:INS-1 [Gene or Genome]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.230: A number of genes and kinases in stress-induced signaling pathways are upregulated in response to chronically elevated FFAs and elevated ROS, including MAPK pathways. 

Phrase: "A number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "kinases in stress-induced signaling pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "upregulated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to chronically"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "elevated ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MAPK pathways."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.231: This is illustrated by a recent study by Kaneto et al. 

Phrase: "This"

Phrase: "is"

Phrase: "illustrated by a recent study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332185:Recent [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "by Kaneto et al."
Processing 00000000.tx.232: (47) that shows activation of JNK, p38 MAPK, and PKC in response to oxidative stress in rat islets, which precedes the downregulation of insulin gene expression and secretion. 

Phrase: "(47"

Phrase: ")"

Phrase: "that"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "activation of JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKC in response"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C1168438:Protein C [Laboratory Procedure]
   797   C1418943:PROTEIN C [Gene or Genome]
   797   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "in rat islets,"

Phrase: "which"

Phrase: "precedes"

Phrase: "the downregulation of insulin gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0920533:Gene Down-Regulation [Genetic Function]
   753   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "and"

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.233: In the present study, we see significant OA-induced upregulation of the JNK3 gene and JNK3, PKC, and p38 MAPK levels. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "significant OA-induced upregulation of the JNK3 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0041904:Up-Regulation [Cell Function,Molecular Function]
   742   C0162493:Up-Regulation [Genetic Function]

Phrase: "and"

Phrase: "JNK3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334478:JNK3 [Gene or Genome]
  1000   C1708803:JNK3 [Gene or Genome]

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "p38 MAPK levels."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   822   C0428479:Protein level [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.234: Interestingly, among the candidates significantly induced by OA was the VILIP-1 gene encoding a Ca2+ sensor protein, which was upregulated three- to fourfold, a finding confirmed by Western blot. 

Phrase: "Interestingly,"

Phrase: "among the candidates significantly"

Phrase: "induced by OA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   833   C0028929:Oleic Acid [Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "the VILIP-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   722   C1421472:VISININ-LIKE 1 [Gene or Genome]
   717   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a Ca2+ sensor protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "was"

Phrase: "upregulated"

Phrase: "three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to fourfold,"

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "confirmed by Western blot."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1705493:Western [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.235: VILIP-1 belongs to a family of Ca2+ sensor proteins, including neuronal Ca2+ sensor-1 (NCS-1), which has been shown to enhance exocytosis in neurons and neuroendocrine cells (48). 

Phrase: "VILIP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]
   923   C1421472:VISININ-LIKE 1 [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "belongs to a family of Ca2+ sensor proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   750   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0015576:Family [Family Group]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0183210:Sensor [Medical Device]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1704727:Family [Conceptual Entity]
   744   C1705193:Sensor [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "neuronal Ca2+ sensor-1 (NCS-1),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0183210:Sensor [Medical Device]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1705193:Sensor [Manufactured Object]
   741 E C0027882:Neuron [Cell]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "exocytosis in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "neuroendocrine cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1518275:Neuroendocrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027912:Neuroendocrine [Body System]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.236: VILIP-1 has been implicated in the modulation of cAMP and cGMP signaling pathways in neural cells (49,50). 

Phrase: "VILIP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]
   923   C1421472:VISININ-LIKE 1 [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the modulation of cAMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "cGMP signaling pathways in neural cells"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C0027792:Neural Pathways [Body Part, Organ, or Organ Component]
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.237: However, despite being first identified in the pancreatic -cell, its function in this cell type remains unknown. 

Phrase: "However,"

Phrase: "despite"

Phrase: "being"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified in the pancreatic -cell,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0205396:Identified [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "its function in this cell type remains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0007613:Cell Function [Cell Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.238: OA also upregulated gene expression of Sdf-1 by two- to fourfold, as well as its protein levels (Table 1, Fig. 4). 

Phrase: "OA also upregulated gene expression of Sdf-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017262:Gene Expression [Genetic Function]
   751   C1861886:CELL Gene [Gene or Genome]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by two-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "to fourfold,"

Phrase: "as well as"

Phrase: "its protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.239: Upregulation of Sdf-1 gene expression in response to elevated FFAs has previously been noted by Busch et al. 

Phrase: "Upregulation of Sdf-1 gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0041904:Up-Regulation [Cell Function,Molecular Function]
   742   C0162493:Up-Regulation [Genetic Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to elevated FFAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0015688:Free Fatty Acids [Lipid]
   890 E C2698488:Free Fatty Acid [Laboratory Procedure]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "noted by Busch et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.240: (6). 

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.241: Sdf-1 is a highly potent chemoattractant for monocytes and naive T-cells (51) and has been implicated in the recruitment of autoreactive B-cells in the development of type 1 diabetes (52). 

Phrase: "Sdf-1"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]
   840   C0162597:Stromal cell [Cell]
   804   C0007634:Cell [Cell]
   804 E C0596291:stroma cell [Cell Component]
   804   C1269647:Cell [Cell]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]
   733   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a highly potent chemoattractant for monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0008013:chemoattractant [Biologically Active Substance]

Phrase: "and"

Phrase: "naive T-cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C3641721:Naive T Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(51"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the recruitment of autoreactive B-cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0004561:B-Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C2949735:Recruitment [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.242: This raises the possibility that an increase in Sdf-1 could exacerbate the loss of -cells seen with the progression of type 2 diabetes. 

Phrase: "This"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that"

Phrase: "an increase in Sdf-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0442805:Increase [Functional Concept]
   703   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   703   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]

Phrase: "could"

Phrase: "exacerbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "the loss of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "seen with the progression of type 2 diabetes."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0205397:Seen [Qualitative Concept]
   744   C0242656:progression [Pathologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0449258:Progression [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]
Processing 00000000.tx.243: Reports have implicated elevated UCP2 levels as a mechanism for the blunted GSIS evident following chronic exposure to elevated FFA (17). 

Phrase: "Reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "implicated"

Phrase: "elevated UCP2 levels as a mechanism"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "for the blunted GSIS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "chronic exposure to elevated FFA (17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: ")."
Processing 00000000.tx.244: Recent studies using Northern blot hybridization found increased levels of UCP2 gene expression after exposure to fatty acids in INS-1 cells (16,33,53). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Northern blot hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0599862:northern hybridization [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]
   734   C0005861:Northern Blot [Molecular Biology Research Technique]
   734   C1621557:Northern Blot [Research Device]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "increased levels of UCP2 gene expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(16,"

Phrase: "33,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.245: Expression of the UCP2 gene was not detectable by microarray analysis in this study, and there is no report of UCP2 regulation in response to elevated FFA levels in other studies using the microarray technique (6). 

Phrase: "Expression of the UCP2 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not detectable by microarray analysis"

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "no report of UCP2 regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to elevated FFA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the microarray technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.246: However, real-time PCR detected UCP2 transcripts, and the level of UCP2 mRNA expression increased 4.0-fold after OA treatment (data not shown). 

Phrase: "However,"

Phrase: "real-time PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "UCP2 transcripts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the level of UCP2 mRNA expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3244092:expression level [Idea or Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "4.0-fold after OA treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.247: These results demonstrate one limitation of microarray analysis, the detection of genes that are expressed at relatively low levels. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "one limitation of microarray analysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449295:Limitation [Functional Concept]

Phrase: "the detection of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "expressed at relatively low levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205251:low [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.248: In summary, our findings suggest that chronic exposure to OA impairs -cell function through ROS-dependent and -independent pathways. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that chronic exposure to OA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "impairs -"

Phrase: "cell function through ROS-dependent"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007613:Cell Function [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]

Phrase: "and -"

Phrase: "independent pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.249: Downregulation of genes involved in cell growth/differentiation and protein synthesis may, in part, lead to decreased insulin content through a ROS-dependent pathway. 

Phrase: "Downregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0920533:Gene Down-Regulation [Genetic Function]
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell growth/differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "may"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "lead to decreased insulin content"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0423896:Content [Mental Process]
   760   C0442797:decreased [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C0547047:Decrease [Quantitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "through a ROS-dependent pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.250: OA-induced oxidative stress modulates kinase signaling pathways, including inactivation of p70S6K and upregulation of p38 MAPK, JNK3, and PKC may contribute to the deterioration of -cells. 

Phrase: "OA-induced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   804   C0038435:Stress [Finding]
   804   C0311404:Oxidative [Functional Concept]
   733 E C0231297:Stressful [Functional Concept]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "kinase signaling pathways,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "inactivation of p70S6K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "upregulation of p38 MAPK,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]
   731   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   713 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "JNK3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334478:JNK3 [Gene or Genome]
  1000   C1708803:JNK3 [Gene or Genome]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "contribute to the deterioration of -cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0868945:Deterioration [Phenomenon or Process]
   753   C1880177:Contribute [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.251: Taken together, these finding have identified several candidate molecules for further investigation into the mechanism of lipotoxicity in pancreatic -cells.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "have"

Phrase: "identified several candidate molecules for further investigation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "into the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "of lipotoxicity"

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.252: ACKNOWLEDGMENTS  This study was funded by the Canadian Institutes of Health Research (CIHR) (MOP-12898 to M.B.W. and C.B.C.) and the Canadian Diabetes Association (to M.B.W. and S.D.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "funded by the Canadian Institutes of Health Research (CIHR)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C0035172:Research Institutes [Organization]
   767   C0681805:funded research [Research Activity]
   744   C0016820:funded [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C0035168:research [Research Activity]
   744   C0238884:CANADIAN [Finding]
   744   C0242481:Research [Research Activity]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "(MOP-12898 to M.B.W."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "C.B.C.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "the Canadian Diabetes Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "("

Phrase: "to M.B.W."

Phrase: "and S."

Phrase: "D."

Phrase: ")."
Processing 00000000.tx.253: M.B.W. is a CIHR Investigator. 

Phrase: "M.B.W."

Phrase: "is"

Phrase: "a CIHR Investigator."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0035172:Research Institutes [Organization]
   748   C0021622:Institutes [Organization]
   714 E C1272753:Institute [Idea or Concept]
Processing 00000000.tx.254: X.W. is supported by a CIHR New Emerging Team Grant in Diabetes Complications, and H.L. is supported by the University of Toronto Banting and Best Diabetes Centre (BBDC). 

Phrase: "X.W."

Phrase: "is"

Phrase: "supported by a CIHR"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C1568415:Support of Research [Intellectual Product]
   767   C0035172:Research Institutes [Organization]
   767   C0035176:research supported [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C0035168:research [Research Activity]
   744   C0238884:CANADIAN [Finding]
   744   C0242481:Research [Research Activity]
   744   C1521721:Supported [Conceptual Entity]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "New Emerging Team Grant in Diabetes Complications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018173:Grant [Quantitative Concept]
   748   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "H.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346686:h l [Quantitative Concept]

Phrase: "is"

Phrase: "supported by the University of Toronto Banting and Best Diabetes Centre (BBDC)."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]
   738   C0041740:University [Manufactured Object,Organization]
   738   C0205099:Center [Spatial Concept]
   738   C1521721:Supported [Conceptual Entity]
   738   C1522427:Best [Qualitative Concept]
   704 E C0183683:Support [Medical Device]
Processing 00000000.tx.255: We thank Patrick MacDonald and Daphne Yau (Department of Physiology, University of Toronto) for their contributions to this work and the BBDC for pilot funding.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Patrick MacDonald"

Phrase: "and"

Phrase: "Daphne Yau"

Phrase: "(Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Toronto"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "for their contributions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribution [Activity]

Phrase: "to this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "and"

Phrase: "the BBDC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0011849:Diabetes [Disease or Syndrome]
   799   C0205099:Center [Spatial Concept]
   799   C1522427:Best [Qualitative Concept]

Phrase: "for pilot funding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243098:Funding [Quantitative Concept]
   861   C0376244:funding [Quantitative Concept]
Processing 00000000.tx.256: FOOTNOTES  * X.W. and H.L. contributed equally to this study. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "* X.W."

Phrase: "and"

Phrase: "H.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346686:h l [Quantitative Concept]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.257: Address correspondence and reprint requests to Michael B. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Michael B."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.258: Wheeler, University of Toronto, Department of Physiology, 1 Kings College Cir., Room 3352, Toronto ON, M5S 1A8. 

Phrase: "Wheeler,"

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "1 Kings College Cir.,"

Phrase: "Room 3352,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "Toronto ON,"

Phrase: "M5S 1A8."
Processing 00000000.tx.259: E-mail: michael.wheeler{at}utoronto.ca Received for publication December 5, 2002 and accepted in revised form September 30, 2003 CHX, cycloheximide; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "michael.wheeler{at}utoronto.ca"

Phrase: "Received for publication December 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2002"

Phrase: "and"

Phrase: "accepted in revised form September 30,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2003 CHX,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   805 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.260: DMEM, Dulbeccos modified Eagles medium; 

Phrase: "DMEM,"

Phrase: "Dulbeccos modified Eagles medium"

Phrase: ";"
Processing 00000000.tx.261: EST, expressed sequence tag; 

Phrase: "EST,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0600510:Expressed Sequence Tag [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0037293:Tag [Neoplastic Process]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0181496:Tag [Manufactured Object]
   827   C1519249:Sequence [Functional Concept]
   827   C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "expressed sequence tag"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0600510:Expressed Sequence Tag [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0037293:Tag [Neoplastic Process]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0181496:Tag [Manufactured Object]
   827   C1519249:Sequence [Functional Concept]
   827   C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.262: FFA, free fatty acid; 

Phrase: "FFA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015688:FFA [Lipid]

Phrase: "free fatty acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0015688:free fatty acid [Lipid]
  1000   C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.263: GSK, glycogen synthase kinase; 

Phrase: "GSK,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.264: GSIS, glucose-stimulated insulin secretion; 

Phrase: "GSIS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.265: KRB, Krebs-Ringer HEPES buffer; 

Phrase: "KRB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "Krebs-Ringer HEPES buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.266: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.267: MEK, MAPK kinase; 

Phrase: "MEK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MAPK kinase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   958   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.268: NAC, N-acetyl-L-cysteine; 

Phrase: "NAC,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "N-acetyl-L-cysteine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ";"
Processing 00000000.tx.269: OA, oleic acid; 

Phrase: "OA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "oleic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.270: PDK, 3-phosphoinositide-dependent protein kinase; 

Phrase: "PDK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1150639:PDK [Molecular Function]

Phrase: "3-phosphoinositide-dependent protein kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0538677:3-phosphoinositide-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.271: PKB, protein kinase B; 

Phrase: "PKB,"

Phrase: "protein kinase B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.272: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.273: PPAR, peroxisome proliferator-activated receptor; 

Phrase: "PPAR,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: "peroxisome proliferator-activated receptor"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0166418:peroxisome proliferator activated receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]

Phrase: ";"
Processing 00000000.tx.274: Rb, retinoblastoma; 

Phrase: "Rb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: "retinoblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035335:Retinoblastoma [Neoplastic Process]
  1000   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3540616:Retinoblastoma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.275: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.276: SCD, stearoyl-CoA desaturase; 

Phrase: "SCD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038233:Stearoyl-CoA Desaturase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419846:STEAROYL-CoA DESATURASE [Gene or Genome]
   901   C0075202:stearoyl-CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0599871:desaturase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "stearoyl-CoA desaturase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038233:Stearoyl-CoA Desaturase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419846:STEAROYL-CoA DESATURASE [Gene or Genome]
   901   C0075202:stearoyl-CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0599871:desaturase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.277: Sdf, stromal cell-derived factor; 

Phrase: "Sdf,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   861   C0162597:Stromal cell [Cell]
   825 E C0596291:stroma cell [Cell Component]
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
   741   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "stromal cell-derived factor"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   861   C0162597:Stromal cell [Cell]
   825 E C0596291:stroma cell [Cell Component]
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
   741   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.278: TQ, trace quantity; 

Phrase: "TQ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1265611:Quantity [Quantitative Concept]
   861   C1554108:Quantity [Intellectual Product]
   861   C1561573:Quantity [Intellectual Product]

Phrase: "trace quantity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1265611:Quantity [Quantitative Concept]
   861   C1554108:Quantity [Intellectual Product]
   861   C1561573:Quantity [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.279: UCP, uncoupling protein; 

Phrase: "UCP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "uncoupling protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.280: VILIP, visinin-like protein  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Seyffert WA Jr, Madison LL: Physiologic effects of metabolic fuels on carbohydrate metabolism. 

Phrase: "VILIP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "visinin-like protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0753571:Visinin-Like Protein [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Seyffert WA Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Madison LL"

Phrase: ":"

Phrase: "Physiologic effects of metabolic fuels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C2945675:metabolic effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   756   C1372798:Physiological Effects [Physiologic Function]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on carbohydrate metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302820:Carbohydrate Metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.281: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.282: Acute effect of elevation of plasma free fatty acids on hepatic glucose output, peripheral glucose utilization, serum insulin, and plasma glucagon levels. 

Phrase: "Acute effect of elevation of plasma free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on hepatic glucose output,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599782:glucose output [Organ or Tissue Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0205054:Hepatic [Body Location or Region]
   827   C1709366:Output [Conceptual Entity]

Phrase: "peripheral glucose utilization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042153:utilization [Functional Concept]

Phrase: "serum insulin,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0428357:Serum insulin [Laboratory Procedure]
  1000   C1261415:serum insulin [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "plasma glucagon levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C1278023:Plasma glucagon level [Laboratory Procedure]
   884   C0337437:Glucagon level [Laboratory Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.283: Diabetes16 :765 776,1967[Medline] McGarry JD: What if Minkowski had been ageusic? 

Phrase: "Diabetes16"

Phrase: ":"

Phrase: "765 776,"

Phrase: "1967"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McGarry JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "What"

Phrase: "if"

Phrase: "Minkowski"

Phrase: "had"

Phrase: "been"

Phrase: "ageusic?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C2364111:Ageusia [Sign or Symptom]
Processing 00000000.tx.284: An alternative angle on diabetes. 

Phrase: "An alternative angle on diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205143:Angle [Spatial Concept]
Processing 00000000.tx.285: Science258 :766 770,1992[Medline] Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. 

Phrase: "Science258"

Phrase: ":"

Phrase: "766 770,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Unger RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Lipotoxicity in the pathogenesis of obesity-dependent NIDDM"

Phrase: ":"

Phrase: "genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "clinical implications."
Processing 00000000.tx.286: Diabetes44 :863 870,1995[Abstract] Carlsson C, Borg LA, Welsh N: Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. 

Phrase: "Diabetes44"

Phrase: ":"

Phrase: "863 870,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Carlsson C,"

Phrase: "Borg LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Welsh N"

Phrase: ":"

Phrase: "Sodium palmitate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0142904:Sodium Palmitate [Biomedical or Dental Material,Lipid]
   861   C0030233:palmitate [Lipid]
   861   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "partial mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "uncoupling"

Phrase: "and"

Phrase: "reactive oxygen species in rat pancreatic islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1705920:Species [Conceptual Entity]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.287: Endocrinology140 :3422 3428,1999[Abstract/Free FullText] Bollheimer LC, Kestler TM, Michel J, Buettner R, Scholmerich J, Palitzsch KD: Intracellular depletion of insulin by oleate is due to an inhibited synthesis and not to an increased secretion. 

Phrase: "Endocrinology140"

Phrase: ":"

Phrase: "3422 3428,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bollheimer LC,"

Phrase: "Kestler TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Michel J,"

Phrase: "Buettner R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Scholmerich J,"

Phrase: "Palitzsch KD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: ":"

Phrase: "Intracellular depletion of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "by oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "is due to an inhibited synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0220781:synthesis [Biologic Function]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1883254:Synthesis [Activity]
   753   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not to an increased secretion."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.288: Biochem Biophys Res Commun287 :397 401,2001[Medline] Busch AK, Cordery D, Denyer GS, Biden TJ: Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic -cell function. 

Phrase: "Biochem Biophys Res Commun287"

Phrase: ":"

Phrase: "397 401,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Busch AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Cordery D,"

Phrase: "Denyer GS,"

Phrase: "Biden TJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: ":"

Phrase: "Expression profiling of palmitate-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1513400:Expression Profiling [Molecular Biology Research Technique]
   737   C1979963:Profile [Laboratory Procedure]
   737   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "oleate-regulated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "novel insights into the effects of chronic lipid exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:insights [Mental Process]

Phrase: "on pancreatic -cell function."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   913   C0232786:Pancreatic function [Organ or Tissue Function]
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.289: Diabetes51 :977 987,2002[Abstract/Free FullText] Corkey BE, Deeney JT, Yaney GC, Tornheim K, Prentki M: The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "977 987,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Corkey"

Phrase: "BE"

Phrase: ","

Phrase: "Deeney JT,"

Phrase: "Yaney GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Tornheim K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Prentki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "The role of long-chain fatty acyl-CoA esters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in beta-cell signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037083:Signal Transduction [Cell Function]
   812   C1160185:transduction [Organism Function]
   812   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.290: J Nutr130 :299S 304S,2000[Medline] Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M: Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic -cell line INS-1. 

Phrase: "J Nutr130"

Phrase: ":"

Phrase: "299S 304S,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roche E,"

Phrase: "Buteau J,"

Phrase: "Aniento I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Reig JA,"

Phrase: "Soria B,"

Phrase: "Prentki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the immediate-early response genes c-fos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C1415884:IMMEDIATE-EARLY RESPONSE GENE [Gene or Genome]
   700   C0206256:Genes, Immediate-Early [Gene or Genome]

Phrase: "and"

Phrase: "nur-77 in the pancreatic -cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.291: Diabetes48 :2007 2014,1999[Abstract] Yoshikawa H, Tajiri Y, Sako Y, Hashimoto T, Umeda F, Nawata, H: Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2007 2014,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yoshikawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tajiri Y,"

Phrase: "Sako Y,"

Phrase: "Hashimoto T,"

Phrase: "Umeda F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Nawata,"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Effects of free fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on beta-cell functions"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   901   C0007613:cell functions [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Functions [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "a possible involvement of peroxisome proliferator-activated receptors alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1314939:Involvement [Functional Concept]

Phrase: "or"

Phrase: "pancreatic/duodenal homeobox."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242303:Homeo Box [Gene or Genome]
   827   C0598306:Homeo Box [Spatial Concept]
Processing 00000000.tx.292: Metabolism50 :613 618,2001[Medline] Xiao J, Gregersen S, Kruhoffer M, Pedersen SB, Orntoft TF, Hermansen K: The effect of chronic exposure to fatty acids on gene expression in clonal insulin-producing cells: studies using high density oligonucleotide microarray. 

Phrase: "Metabolism50"

Phrase: ":"

Phrase: "613 618,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xiao J,"

Phrase: "Gregersen S,"

Phrase: "Kruhoffer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pedersen SB,"

Phrase: "Orntoft TF,"

Phrase: "Hermansen K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "The effect of chronic exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "to fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "on gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in clonal insulin-producing cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   867   C0009013:Clone Cells [Cell]
   858   C0030281:Insulin Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "high density oligonucleotide microarray."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709016:High-Density Microarray [Manufactured Object]
           Microarray
   861   C0600597:Oligonucleotide Microarray [Medical Device,Research Device]
Processing 00000000.tx.293: Endocrinology142 :4777 4784,2001[Abstract/Free FullText] Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M: Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic -cell line INS-1. 

Phrase: "Endocrinology142"

Phrase: ":"

Phrase: "4777 4784,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brun T,"

Phrase: "Assimacopoulos-Jeannet F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Corkey"

Phrase: "BE"

Phrase: ","

Phrase: "Prentki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Long-chain fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "acetyl-CoA carboxylase gene expression in the pancreatic -cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017262:Gene Expression [Genetic Function]
   757   C1861886:CELL Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.294: Diabetes46 :393 400,1997[Abstract] Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, Prentki M: Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. 

Phrase: "Diabetes46"

Phrase: ":"

Phrase: "393 400,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Assimacopoulos-Jeannet F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Thumelin S,"

Phrase: "Roche E,"

Phrase: "Esser V,"

Phrase: "McGarry JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Prentki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Fatty acids rapidly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1861886:CELL Gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.295: JBiol Chem272 :1659 1664,1997[Abstract/Free FullText] Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P: Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that -cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. 

Phrase: "JBiol Chem272"

Phrase: ":"

Phrase: "1659 1664,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marselli L,"

Phrase: "Del Guerra S,"

Phrase: "Masini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Santangelo C,"

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Boggi U,"

Phrase: "Piro S,"

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bergamini E,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Mario U,"

Phrase: "Del Prato S,"

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Prolonged exposure to free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0439590:Prolonged [Temporal Concept]

Phrase: "has"

Phrase: "cytostatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010858:cytostatic [Pharmacologic Substance]

Phrase: "and"

Phrase: "pro-apoptotic effects on human pancreatic islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that -cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "partially dependent on ceramide pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.296: Diabetes51 :1437 1442,2002[Abstract/Free FullText] Zhou YP, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "1437 1442,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhou YP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520214:Yp [Nucleotide Sequence]

Phrase: "Grill VE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: ":"

Phrase: "Long-term exposure of rat pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]

Phrase: "to fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "biosynthesis through a glucose fatty acid cycle."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0596562:fatty acid biosynthesis [Molecular Function]
   804   C2981166:Fatty acid biosynthesis [Functional Concept]
   774   C0017715:glucose biosynthesis [Molecular Function]
   748   C0005572:biosynthesis [Functional Concept]
   748   C0220781:Biosynthesis [Biologic Function]
Processing 00000000.tx.297: J Clin Invest93 :870 876,1994[Medline] Gremlich S, Bonny C, Waeber G, Thorens B: Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. 

Phrase: "J Clin Invest93"

Phrase: ":"

Phrase: "870 876,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gremlich S,"

Phrase: "Bonny C,"

Phrase: "Waeber G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Thorens B"

Phrase: ":"

Phrase: "Fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "IDX-1 expression in rat pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "reduce"

Phrase: "GLUT2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420172:GLUT2 [Gene or Genome]

Phrase: "glucokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "somatostatin levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.298: J Biol Chem272 :30261 30269,1997[Abstract/Free FullText] Medvedev AV, Robidoux J, Bai X, Cao W, Floering LM, Daniel KW, Collins S: Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. 

Phrase: "J Biol Chem272"

Phrase: ":"

Phrase: "30261 30269,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Medvedev AV,"

Phrase: "Robidoux J,"

Phrase: "Bai X,"

Phrase: "Cao W,"

Phrase: "Floering LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Daniel KW,"

Phrase: "Collins S"

Phrase: ":"

Phrase: "Regulation of the uncoupling protein-2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0017263:Gene Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in"

Phrase: "INS-1 beta-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by oleic acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028928:Oleic Acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0028929:Oleic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.299: J Biol Chem8 :42639 44639,2002 Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM: Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferatoractivated receptor- inhibition. 

Phrase: "J Biol Chem8"

Phrase: ":"

Phrase: "42639 44639,"

Phrase: "2002 Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Piro S,"

Phrase: "Vigneri R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Purrello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rabuazzo"

Phrase: "AM"

Phrase: ":"

Phrase: "Role of ATP production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "uncoupling protein-2 in the insulin secretory defect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   767   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced by chronic exposure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205191:chronic [Temporal Concept]
   770   C0205263:Induced [Functional Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "effects of peroxisome proliferatoractivated receptor- inhibition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.300: Diabetes51 :2749 2756,2002[Abstract/Free FullText] Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB: Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "2749 2756,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chan CB,"

Phrase: "MacDonald PE,"

Phrase: "Saleh MC,"

Phrase: "Johns DC,"

Phrase: "Marban E,"

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Overexpression of uncoupling protein 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glucose-stimulated insulin secretion from rat islets."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.301: Diabetes48 :1482 1486,1999[Abstract] Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB: Increased uncoupling protein-2 levels in -cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "1482 1486,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chan CB,"

Phrase: "De Leo D,"

Phrase: "Joseph JW,"

Phrase: "McQuaid TS,"

Phrase: "Ha XF,"

Phrase: "Xu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Tsushima RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Pennefather PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Salapatek"

Phrase: "AM"

Phrase: ","

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "uncoupling protein-2 levels in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "associated with impaired glucose-stimulated insulin secretion"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "mechanism of action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031327:mechanism of action [Physiologic Function]
  1000   C1524059:mechanism of action [Functional Concept]
   790   C0441712:Mechanism [Functional Concept]
   790   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.302: Diabetes50 :1302 1310,2001[Abstract/Free FullText] Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB: Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "1302 1310,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Baffy G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Perret P,"

Phrase: "Krauss S,"

Phrase: "Peroni O,"

Phrase: "Grujic D,"

Phrase: "Hagen T,"

Phrase: "Vidal-Puig AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: "Boss O,"

Phrase: "Kim YB,"

Phrase: "Zheng XX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450371:XX [Organism Attribute]

Phrase: "Wheeler MB,"

Phrase: "Shulman GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Chan CB,"

Phrase: "Lowell BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "Uncoupling protein-2 negatively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulates"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "a major link between obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "beta cell dysfunction,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1969875:Beta-cell dysfunction [Finding]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0030281:Beta cell [Cell]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.303: Cell105 :745 755,2001[Medline] Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. 

Phrase: "Cell105"

Phrase: ":"

Phrase: "745 755,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arsenijevic D,"

Phrase: "Onuma H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pecqueur C,"

Phrase: "Raimbault S,"

Phrase: "Manning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "BS,"

Phrase: "Miroux B,"

Phrase: "Couplan E,"

Phrase: "Alves-Guerra MC,"

Phrase: "Goubern M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Surwit R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bouillaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Richard D,"

Phrase: "Collins S,"

Phrase: "Ricquier D"

Phrase: ":"

Phrase: "Disruption of the uncoupling protein-2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a role in immunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "reactive oxygen species production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033268:production [Occupational Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
Processing 00000000.tx.304: Nat Genet26 :435 439,2000[Medline] Zraika S, Dunlop M, Proietto J, Andrikopoulos, S: Effects of free fatty acids on insulin secretion in obesity. 

Phrase: "Nat Genet26"

Phrase: ":"

Phrase: "435 439,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zraika S,"

Phrase: "Dunlop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Proietto J,"

Phrase: "Andrikopoulos,"

Phrase: "S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: ":"

Phrase: "Effects of free fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.305: Obes Rev3 :103 112,2002[Medline] Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. 

Phrase: "Obes Rev3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419347:REV3 [Gene or Genome]

Phrase: ":"

Phrase: "103 112,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tiedge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lortz S,"

Phrase: "Drinkgern J,"

Phrase: "Lenzen S"

Phrase: ":"

Phrase: "Relation between antioxidant enzyme gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "antioxidative defense status of insulin-producing cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.306: Diabetes46 :1733 1742,1997[Abstract] Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M: Beneficial effects of antioxidants in diabetes: possible protection of pancreatic -cells against glucose toxicity. 

Phrase: "Diabetes46"

Phrase: ":"

Phrase: "1733 1742,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kaneto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kajimoto Y,"

Phrase: "Miyagawa J,"

Phrase: "Matsuoka T,"

Phrase: "Fujitani Y,"

Phrase: "Umayahara Y,"

Phrase: "Hanafusa T,"

Phrase: "Matsuzawa Y,"

Phrase: "Yamasaki Y,"

Phrase: "Hori M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Beneficial effects of antioxidants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C3179302:Antioxidant Effects [Physiologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "possible protection of pancreatic -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0524828:Cell Protection [Physiologic Function]
   760   C1545588:Protection [Finding]

Phrase: "against glucose toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.307: Diabetes48 :2398 2406,1999[Abstract] Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP: Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2398 2406,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tanaka Y,"

Phrase: "Gleason CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Tran PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Harmon JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Robertson RP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: ":"

Phrase: "Prevention of glucose toxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "in HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Zucker diabetic fatty rats by antioxidants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0034719:Rats, Zucker [Mammal]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
Processing 00000000.tx.308: Proc Natl Acad Sci U S A96 :10857 10862,1999[Abstract/Free FullText] MacDonald PE, Ha XF, Wang J, Smukler SR, Sun AM, Gaisano HY, Salapatek AM, Backx PH, Wheeler, MB: Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion. 

Phrase: "Proc Natl Acad Sci U S A96"

Phrase: ":"

Phrase: "10857 10862,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] MacDonald PE,"

Phrase: "Ha XF,"

Phrase: "Wang J,"

Phrase: "Smukler SR,"

Phrase: "Sun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "AM"

Phrase: ","

Phrase: "Gaisano HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "Salapatek"

Phrase: "AM"

Phrase: ","

Phrase: "Backx PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Wheeler,"

Phrase: "MB"

Phrase: ":"

Phrase: "Members of the Kv1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "Kv2 voltage-dependent K(+)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "regulate"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.309: Mol Endocrinol15 :1423 1435,2001[Abstract/Free FullText] Civelek VN, Deeney JT, Shalosky NJ, Tornheim K, Hansford RG, Prentki M, Corkey BE: Regulation of pancreatic beta-cell mitochondrial metabolism: influence of Ca2+, substrate and ADP. 

Phrase: "Mol Endocrinol15"

Phrase: ":"

Phrase: "1423 1435,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Civelek VN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042658:VN [Geographic Area]
   861   C1336937:VN [Gene or Genome]

Phrase: "Deeney JT,"

Phrase: "Shalosky NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Tornheim K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hansford RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Corkey"

Phrase: "BE"

Phrase: ":"

Phrase: "Regulation of pancreatic beta-cell mitochondrial metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1159402:regulation of metabolism [Organism Function]
           metabolism regulation
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "influence of Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "ADP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]
Processing 00000000.tx.310: Biochem J318 :615 621,1996[Medline] Black MJ, Brandt RB: Spectrofluorometric analysis of hydrogen peroxide. 

Phrase: "Biochem J318"

Phrase: ":"

Phrase: "615 621,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Black MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Brandt RB"

Phrase: ":"

Phrase: "Spectrofluorometric analysis of hydrogen peroxide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.311: Anal Biochem58 :246 254,1974[Medline] Cocco T, Di Paola M, Papa S, Lorusso M: Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. 

Phrase: "Anal Biochem58"

Phrase: ":"

Phrase: "246 254,"

Phrase: "1974"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cocco T,"

Phrase: "Di Paola M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Papa S,"

Phrase: "Lorusso M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Arachidonic acid interaction with the mitochondrial electron transport chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "reactive oxygen species generation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.312: Free Radic Biol Med27 :51 59,1999[Medline] Wang X, Cahill CM, Pineyro MA, Zhou J, Doyle ME, Egan JM: Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. 

Phrase: "Free Radic Biol Med27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1332786:MED27 [Gene or Genome]

Phrase: ":"

Phrase: "51 59,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang X,"

Phrase: "Cahill CM,"

Phrase: "Pineyro MA,"

Phrase: "Zhou J,"

Phrase: "Doyle"

Phrase: "ME,"

Phrase: "Egan JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Glucagon-like peptide-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0061355:Glucagon-Like Peptide 1 [Amino Acid, Peptide, or Protein]
  1000   C1333664:glucagon-like peptide 1 [Gene or Genome]
   923   C0014361:glucagon like peptide [Amino Acid, Peptide, or Protein,Hormone]
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the beta cell transcription factor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "in insulinoma cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.313: Endocrinology140 :4904 4907,1999[Abstract/Free FullText] Wang Y, Egan JM, Raygada M, Nadiv O, Roth J, Montrose-Rafizadeh C: Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 104638 cells. 

Phrase: "Endocrinology140"

Phrase: ":"

Phrase: "4904 4907,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang Y,"

Phrase: "Egan JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Raygada M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nadiv O,"

Phrase: "Roth J,"

Phrase: "Montrose-Rafizadeh C"

Phrase: ":"

Phrase: "Glucagon-like peptide-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0061355:Glucagon-Like Peptide 1 [Amino Acid, Peptide, or Protein]
  1000   C1333664:glucagon-like peptide 1 [Gene or Genome]
   923   C0014361:glucagon like peptide [Amino Acid, Peptide, or Protein,Hormone]
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "messenger ribonucleic acid stability of components of the insulin secretory system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205360:Stability [Qualitative Concept]
   738   C2347098:Stability [Qualitative Concept]

Phrase: "in RIN 104638 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.314: Endocrinology136 :4910 4917,1995[Abstract] Ehses JA, Pelech SL, Pederson RA, McIntosh CH: Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. 

Phrase: "Endocrinology136"

Phrase: ":"

Phrase: "4910 4917,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ehses JA,"

Phrase: "Pelech SL,"

Phrase: "Pederson RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "McIntosh CH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: ":"

Phrase: "Glucose-dependent insulinotropic polypeptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0017132:Glucose-Dependent Insulinotropic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0061126:Glucose-Dependent Insulinotropic Polypeptide [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1415067:GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE [Gene or Genome]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the Raf-Mek1/2-ERK1/2 module"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1709061:Module [Conceptual Entity]

Phrase: "via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1704259:Pathway [Molecular Function]
   791   C1705987:Pathway [Conceptual Entity]
   703   C0010531:Cyclic AMP-Dependent Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.315: JBiol Chem277 :37088 37097,2002[Abstract/Free FullText] Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F: Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? 

Phrase: "JBiol Chem277"

Phrase: ":"

Phrase: "37088 37097,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lameloise N,"

Phrase: "Muzzin P,"

Phrase: "Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Assimacopoulos-Jeannet F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Uncoupling protein 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a possible link between fatty acid excess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "impaired glucose-induced insulin secretion?"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.316: Diabetes50 :803 809,2001[Abstract/Free FullText] McGarry JD, Dobbins RL: Fatty acids, lipotoxicity and insulin secretion. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "803 809,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] McGarry JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Dobbins RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "lipotoxicity"

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.317: Diabetologia42 :128 138,1999[Medline] Burkart V, Koike T, Brenner HH, Kolb H: Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "128 138,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Burkart V,"

Phrase: "Koike T,"

Phrase: "Brenner HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Kolb H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Oxygen radicals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0162772:Oxygen Radicals [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0302912:radicals [Chemical Viewed Structurally]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "generated by the enzyme xanthine oxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0043317:Xanthine Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1421531:XANTHINE OXIDASE [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0043314:xanthine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0043318:xanthine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3146294:Generated [Activity]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "rat pancreatic islet cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   906   C0734999:Pancreatic islet cell [Cell]
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.318: Diabetologia35 :1028 1034,1992[Medline] Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y: Hyperglycemia causes oxidative stress in pancreatic -cells of GK rats, a model of type 2 diabetes. 

Phrase: "Diabetologia35"

Phrase: ":"

Phrase: "1028 1034,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ihara Y,"

Phrase: "Toyokuni S,"

Phrase: "Uchida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Odaka H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka T,"

Phrase: "Ikeda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hiai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Seino Y,"

Phrase: "Yamada Y"

Phrase: ":"

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "oxidative stress in pancreatic -cells of GK rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   744   C0038435:Stress [Finding]
   744   C0311404:Oxidative [Functional Concept]

Phrase: "a model of type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.319: Diabetes48 :927 932,1999[Abstract] Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG: Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "927 932,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cnop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hannaert JC,"

Phrase: "Hoorens A,"

Phrase: "Eizirik DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Pipeleers DG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: ":"

Phrase: "Inverse relationship between cytotoxicity of free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "in pancreatic islet cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   983   C0734999:Pancreatic islet cell [Cell]
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cellular triglyceride accumulation."
Processing 00000000.tx.320: Diabetes50 :1771 1777,2001[Abstract/Free FullText] Ntambi JM: Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "1771 1777,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ntambi JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Regulation of stearoyl-CoA desaturase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by polyunsaturated fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0032615:Polyunsaturated Fatty Acids [Biologically Active Substance,Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "cholesterol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]
Processing 00000000.tx.321: J Lipid Res40 :1549 1558,1999[Abstract/Free FullText] Tebbey PW, Buttke TM: Arachidonic acid regulates unsaturated fatty acid synthesis in lymphocytes by inhibiting stearoyl-CoA desaturase gene expression. 

Phrase: "J Lipid Res40"

Phrase: ":"

Phrase: "1549 1558,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tebbey PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Buttke TM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: ":"

Phrase: "Arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "regulates"

Phrase: "unsaturated fatty acid synthesis in lymphocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C2263126:unsaturated fatty acid synthesis [Molecular Function]
   833   C0596562:fatty acid synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "by inhibiting stearoyl-CoA desaturase gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.322: Biochim Biophys Acta1171 :27 34,1992[Medline] Liang Y, Buettger C, Berner DK, Matschinsky FM: Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9). 

Phrase: "Biochim Biophys Acta1171"

Phrase: ":"

Phrase: "27 34,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liang Y,"

Phrase: "Buettger C,"

Phrase: "Berner DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Matschinsky FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "Chronic effect of fatty acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205191:chronic [Temporal Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "not through the alteration of glucose metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1382395:Glucose Metabolism Alteration [Organ or Tissue Function]
   778   C0596620:glucose metabolism [Molecular Function]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
   748   C1515926:Alteration [Idea or Concept]
   748   C1518422:Not [Functional Concept]

Phrase: "in a pancreatic beta-cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   756   C0030281:Pancreatic beta cell [Cell]

Phrase: "(beta HC9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419006:HC9 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.323: Diabetologia40 :1018 1027,1997[Medline] Segall L, Lameloise N, Assimacopoulos-Jeannet F, Roche E, Corkey P, Thumelin S, Corkey BE, Prentki M: Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. 

Phrase: "Diabetologia40"

Phrase: ":"

Phrase: "1018 1027,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Segall L,"

Phrase: "Lameloise N,"

Phrase: "Assimacopoulos-Jeannet F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Roche E,"

Phrase: "Corkey P,"

Phrase: "Thumelin S,"

Phrase: "Corkey"

Phrase: "BE"

Phrase: ","

Phrase: "Prentki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "rather than"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "implicated in altered insulin secretion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0392747:Altered [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "caused by oleate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0133788:oleate [Lipid]
   790   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "in"

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.324: Am J Physiol277 :E521 E528,1999[Medline] Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ: Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. 

Phrase: "Am"

Phrase: "J Physiol277"

Phrase: ":"

Phrase: "E521 E528,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bollheimer LC,"

Phrase: "Skelly RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Chester MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "McGarry JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Rhodes CJ"

Phrase: ":"

Phrase: "Chronic exposure to free fatty acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0205191:chronic [Temporal Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "reduces"

Phrase: "pancreatic beta cell insulin content by increasing basal insulin secretion"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0020459:increasing insulin [Disease or Syndrome]
   757   C0030281:Insulin Cell [Cell]
   757   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   757   C1256369:insulin secretion [Cell Function]
   744   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "compensated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205432:Compensated [Qualitative Concept]

Phrase: "by a corresponding increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in proinsulin biosynthesis translation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040712:Translation [Intellectual Product]
   827   C0597295:translation [Molecular Function]
   827   C1519614:Translation [Genetic Function]
Processing 00000000.tx.325: J Clin Invest101 :1094 1101,1998[Abstract/Free FullText] Furukawa H, Carroll RJ, Swift HH, Steiner DF: Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic -cell line MIN6. 

Phrase: "J Clin Invest101"

Phrase: ":"

Phrase: "1094 1101,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Furukawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carroll RJ,"

Phrase: "Swift HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Steiner DF"

Phrase: ":"

Phrase: "Long-term elevation of free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "leads to delayed processing of proinsulin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0181586:leads [Medical Device]
   753   C0205421:Delayed [Temporal Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1709694:Processing [Activity]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3272602:Delayed [Qualitative Concept]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "prohormone convertases 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0083957:Prohormone Convertase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1258132:Prohormone Convertases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "and"

Phrase: "3 in the pancreatic -cell line MIN6."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0205132:Line [Spatial Concept]
   748   C0439086:<3 [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2827736:3+ [Quantitative Concept]
   748   C2981702:3+ [Classification]
Processing 00000000.tx.326: Diabetes48 :1395 1401,1999[Abstract] Ferrari S, Thomas G: S6 phosphorylation and the p70s6k/p85s6k. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "1395 1401,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ferrari S,"

Phrase: "Thomas G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "S6 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "the p70s6k/p85s6k."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136238:p85s6k [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.327: Crit Rev Biochem Mol Biol29 :385 413,1994[Abstract] Saxena P, Houk M, Webb G: ATP levels coordinate proinsulin synthesis and insulin secretion in pancreatic beta cells (Abstract). 

Phrase: "Crit Rev Biochem Mol Biol29"

Phrase: ":"

Phrase: "385 413,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Saxena P,"

Phrase: "Houk M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Webb G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "ATP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "coordinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "proinsulin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "insulin secretion in pancreatic beta cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   783   C0030296:Pancreatic Secretion [Body Substance]
   783   C0232787:Pancreatic secretion [Organ or Tissue Function]
   767   C0030281:Insulin Cell [Cell]
   767   C1327616:Cell secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.328: Diabetes52 (Suppl. 1) :A380 ,2003 Dickson LM, Lingohr MK, McCuaig J, Hugl SR, Snow L, Kahn BB, Myers MG Jr, Rhodes CJ: Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1). 

Phrase: "Diabetes52"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "A380 ,"

Phrase: "2003 Dickson LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1261082:LM [Body Part, Organ, or Organ Component]
   827   C1551056:lm [Quantitative Concept]
   827   C2981682:LM [Quantitative Concept]

Phrase: "Lingohr MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "McCuaig J,"

Phrase: "Hugl SR,"

Phrase: "Snow L,"

Phrase: "Kahn BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Myers MG Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Rhodes CJ"

Phrase: ":"

Phrase: "Differential activation of protein kinase B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C1819042:protein kinase B activation [Cell Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0753627:P70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705582:P70 [Gene or Genome]
  1000   C1836606:p70 [Gene or Genome]

Phrase: "(S6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419024:S6 [Gene or Genome]
  1000   C1419741:S6 [Gene or Genome]
  1000   C1861424:S6 [Gene or Genome]
  1000   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "K by glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "insulin-like growth factor 1 in pancreatic beta-cells"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   849   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   815   C2714958:Pancreatic Beta Cell Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0007595:cells growth [Cell Function]
   745   C0030281:Insulin Cell [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "("

Phrase: "INS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.329: J Biol Chem276 :21110 21120,2001[Abstract/Free FullText] Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC: Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. 

Phrase: "J Biol Chem276"

Phrase: ":"

Phrase: "21110 21120,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kaneto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Xu G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Fujii N,"

Phrase: "Kim S,"

Phrase: "Bonner-Weir S,"

Phrase: "Weir GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: ":"

Phrase: "Involvement of c-Jun N-terminal kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in oxidative stress-mediated suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0221103:Suppression [Pathologic Function]
   812   C0301625:Suppression [Organism Function]
   812   C0439181:% suppression [Quantitative Concept]
   812   C0728721:suppression [Mental Process]

Phrase: "of insulin gene expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.330: J Biol Chem277 :30010 30018,2002[Abstract/Free FullText] Pongs O, Lindemeier J, Zhu XR, Theil T, Engelkamp D, Krah-Jentgens I, Lambrecht HG, Koch KW, Schwemer J, Rivosecchi R: Frequenin: a novel calcium-binding protein that modulates synaptic efficacy in the Drosophila nervous system. 

Phrase: "J Biol Chem277"

Phrase: ":"

Phrase: "30010 30018,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pongs O,"

Phrase: "Lindemeier J,"

Phrase: "Zhu XR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707968:XR [Biomedical or Dental Material]
   861   C1962945:XR [Diagnostic Procedure]

Phrase: "Theil T,"

Phrase: "Engelkamp D,"

Phrase: "Krah-Jentgens I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lambrecht HG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "Koch KW,"

Phrase: "Schwemer J,"

Phrase: "Rivosecchi R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Frequenin"

Phrase: ":"

Phrase: "a novel calcium-binding protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
   923   C1822659:calcium binding protein [Gene or Genome]
   875   C0805431:Calcium/Protein [Quantitative Concept]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1516144:Calcium Binding [Molecular Function]
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C2936886:Calcium [Pharmacologic Substance]

Phrase: "that"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "synaptic efficacy in the Drosophila nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:Efficacy [Qualitative Concept]
   748   C1707887:EFFICACY [Research Activity]
Processing 00000000.tx.331: Neuron11 :15 28,1993[Medline] Braunewell KH, Spilker C, Behnisch T, Gundelfinger ED: The neuronal calcium-sensor protein VILIP modulates cyclic AMP accumulation in stably transfected C6 glioma cells: amino-terminal myristoylation determines functional activity. 

Phrase: "Neuron11"

Phrase: ":"

Phrase: "15 28,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braunewell KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Spilker C,"

Phrase: "Behnisch T,"

Phrase: "Gundelfinger ED"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: ":"

Phrase: "The neuronal calcium-sensor protein VILIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "cyclic AMP accumulation in stably transfected C6 glioma cells"

Phrase: ":"

Phrase: "amino-terminal myristoylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598434:myristoylation [Molecular Function]

Phrase: "determines"

Phrase: "functional activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.332: J Neurochem68 :2129 2139,1997[Medline] Braunewell KH, Brackmann M, Schaupp M, Spilker C, Anand R, Gundelfinger ED: Intracellular neuronal calcium sensor (NCS) protein VILIP-1 modulates cGMP signalling pathways in transfected neural cells and cerebellar granule neurones. 

Phrase: "J Neurochem68"

Phrase: ":"

Phrase: "2129 2139,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braunewell KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Brackmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schaupp M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Spilker C,"

Phrase: "Anand R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gundelfinger ED"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: ":"

Phrase: "Intracellular neuronal calcium sensor (NCS) protein VILIP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   890   C0529863:neuronal calcium sensor 1 [Amino Acid, Peptide, or Protein,Receptor]
   890   C1414814:NEURONAL CALCIUM SENSOR 1 [Gene or Genome]
   834   C1421472:VISININ-LIKE 1 [Gene or Genome]
   807   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0078351:visinin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "cGMP signalling pathways in transfected neural cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0027792:Neural Pathways [Body Part, Organ, or Organ Component]
   762   C0037080:Signal Pathways [Molecular Function]
   762   C0037083:signalling pathway [Cell Function]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "cerebellar granule neurones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0027882:Neurone [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.333: J Neurochem78 :1277 1286,2001[Medline] Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chemoattractant Sdf-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. 

Phrase: "J Neurochem78"

Phrase: ":"

Phrase: "1277 1286,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bleul CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "Farzan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Choe H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Parolin C,"

Phrase: "Clark-Lewis I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sodroski J,"

Phrase: "Springer TA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: ":"

Phrase: "The lymphocyte chemoattractant Sdf-1"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   913   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]
   884   C0065337:Lymphocyte Chemoattractant Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1334106:LYMPHOCYTE CHEMOATTRACTANT FACTOR [Gene or Genome]
   884   C1522250:Lymphocyte Chemoattractant Factor [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   818   C0162597:Stromal cell [Cell]
   795   C0007634:Cell [Cell]
   795   C1269647:Cell [Cell]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C3245521:derived [Idea or Concept]
   782 E C0596291:stroma cell [Cell Component]
   724   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a ligand for LESTR/fusin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023688:Ligand [Chemical]

Phrase: "and"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "HIV-1 entry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1705654:Entry [Intellectual Product]
   734   C0019704:HIV-1 [Virus]
Processing 00000000.tx.334: Nature382 :829 833,1996[Medline] Matin K, Salam MA, Akhter J, Hanada N, Senpuku H: Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice. 

Phrase: "Nature382"

Phrase: ":"

Phrase: "829 833,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matin K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Salam MA,"

Phrase: "Akhter J,"

Phrase: "Hanada N,"

Phrase: "Senpuku H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Role of stromal-cell derived factor-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
   731   C0218504:Stromal Cell-Derived Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   731   C1332817:STROMAL CELL-DERIVED FACTOR 1 [Gene or Genome]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of autoimmune diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004364:Autoimmune Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0443146:Autoimmune [Pathologic Function]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "in non-obese diabetic mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   886   C1513853:NON Mouse [Mammal]
   875   C0025933:Mice, Obese [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0028754:Obese [Disease or Syndrome]
   812   C0241863:DIABETIC [Finding]
   812   C1518422:Non [Functional Concept]
Processing 00000000.tx.335: Immunology107 :222 232,2002[Medline] Li LX, Skorpen F, Egeberg K, Jorgensen IH, Grill V: Induction of uncoupling protein 2 mRNA in beta-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. 

Phrase: "Immunology107"

Phrase: ":"

Phrase: "222 232,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li LX,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441916:LX [Finding]
   861   C0560137:lx [Quantitative Concept]

Phrase: "Skorpen F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Egeberg K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Jorgensen IH,"

Phrase: "Grill V"

Phrase: ":"

Phrase: "Induction of uncoupling protein 2 mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in beta-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "stimulated by oxidation of fatty acids"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   814   C1158366:acids fatty oxidation [Molecular Function]
   790   C0015684:Fatty Acids [Lipid]
   753   C0001128:Acids [Chemical]
   753   C0030011:Oxidation [Molecular Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "but"

Phrase: "not by nutrient oversupply."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678695:Nutrient [Food]
   770   C1518422:Not [Functional Concept]
   770   C2347375:Nutrient [Conceptual Entity]
Processing 00000000.tx.336: Endocrinology143 :1371 1377,2002[Abstract/Free FullText]

Phrase: "Endocrinology143"

Phrase: ":"

Phrase: "1371 1377,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

